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The complete genome of snakehead rhabdovirus (SHRV) was cloned and
molecularly characterized. This was initially accomplished through the sequence
determination of its glycoprotein gene and the phylogenetic analysis of this gene with
orthologous genes from other rhabdoviruses. The phylogenetic analysis revealed that
SHRV groups with viruses of the genus Novirhabdovirus. The full-length glycoprotein
was expressed in mammalian cells to investigate its potential use in the production of
pseudotyped retroviruses.
The sequence of the entire SHRV genome of 11.6 kb was determined, and all
encoded proteins, intergenic transcriptional control motifs, and the leader and trailer
regions were identified. The genome was found to encode six proteins including a
nucleoprotein, a phosphoprotein, a matrix protein, a glycoprotein, a small--presumably
non-virion--protein, and a polymerase protein. The presence of a non-virion protein,
which is the hallmark feature of all Novirhabdoviruses, supported SHRV's identity as a
member of the Novirhabdovirus genus, despite the fact that the non-virion protein
showed no homology with any known protein.
A system was developed to express a full-length, error-free positive-strand copy
of SHRV's RNA genome along with all of the SHRV proteins required for viral
replication within the cytoplasm of a virus-susceptible host cell. These factors
collectively allowed the recovery of live virus entirely from cloned cDNAs. A unique
restriction site was engineered into SHRV's cDNA genome, and the presence of this
restriction site was verified following virus recovery, proving the recovered virus was
indeed a live recombinant virus. To our knowledge this achievement marks the first time
in which reverse genetics has been performed on a nonmammalian negative-stranded
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Rhabdoviruses and their History 
Rhabdovirus History 
it has only been in recent decades that we have begun to understand the true 
nature of the ultramicroscopic obligate intracellular pathogens known as viruses; yet 
humankind has long recognized that these "lifeless organisms" have had a major role 
in human history. Viruses belonging to the family Rhabdoviridae are no exception in 
this. Although there are several rhabdoviruses which have had an important effect on 
history, clearly the one with the longest and most colorful history is the rabies virus. 
The word rabies comes from the Sanskrit word "rabhas" which means "to do 
violence" (Baer, 1991). Indeed, most words used to describe the disease caused by 
the rabies virus are synonymous with violence and madness. References to rabies in 
Greek mythology were common; in fact, the Greeks even had a special god, 
Arisaeus, son of Apollo, to counteract the effects of rabies (Baer, 1991). Rabies is 
the manifestation of a virus which infects the nervous system, inducing a kind of 
madness, and thus becoming one of the most fascinating yet dreaded diseases in 
human history. As George Baer (1991) expresses it, "Rabies is a unique virus in 
that it manages to exit in the saliva when its host is stimulated to bite  a mean 
accomplishment. 
While rabies has historically been the model rhabdovirus, it has taken a back 
seat to the rhabdovirus vesicular stomatitis virus (VSV) as the model for scientific 
exploration. VSV has been reported to infect humans, but is primarily a pathogen of 
cattle, horses, and swine, causing severe lesions on the feet and in the mouths of 
infected animals (Bishop, 1979). The first reports of VSV infections occurred in the 
early 1800s, exclusively in the United States (Bishop, 1979). Unlike rabies, which 
is only known to infect mammals, VSV has an extremely broad host range and even 2 
infects insects (Novella et al., 1995), which are likely intermediate hosts for the 
virus. VSV has not played as significant a historical role as rabies, yet during the 
American Civil War it had a brief but profound effect on history when it was credited 
with disabling nearly 4000 horses in a severe outbreak (Bishop, 1979). Problems 
with VSV still persist today in the western hemisphere's livestock. 
The process of coming to understand and eventually harness the biology of 
rhabdoviruses took over 100 years of small yet notable steps. The first scientist to 
truly make progress in the understanding of rhabdoviruses was Louis Pasteur. In a 
time when many scientists were working on artificially transmitting  the rabies 
disease, Pasteur was the first to realize that the rabies infection emanated from the 
central nervous system. More importantly, he came the closest of any scientist in his 
time period to describing rabies as a virus when he stated that "one is tempted to 
believe that a microbe of infinite smallness, having the form neither of a bacillus nor 
a micrococcus is the cause." (Pasteur et al., 1884).  Although Pasteur's additions to 
our knowledge of rabies biology have been noted,  his claim to fame was not for his 
advances in the understanding of the virus' basic biology, but his progress in 
developing a rabies virus vaccine. 
The next big step in the study of rhabdovirus biology was the cultivation of 
VSV in tissue cultured cells in the 1920s and 30s (reviewed in Bishop, 1979). This 
was the step which probably made VSV an attractive model for rhabdovirus study. 
While rabies was a virus of the nervous system with its own peculiarities in tissue 
culture, VSV was a workhorse virus with a broad host range, rapid cytopathic effect 
(CPE), and generally high titer virus yields. 
Between 1954 and 1963, electron microscope (EM) images of VSV and 
rabies virus became available and the similar bullet-shaped morphology of these two 
viruses was realized for the first time (for review see (Bishop, 1979)).  From this 
point forward, the rhabdovirus family was defined more by its morphology than any 
other feature. In 1966, the term rhabdovirus, from the Greek  word "rhabdos," 
meaning "a rod," first emerged in describing this family of viruses (Melnick & 
McCombs, 1966), and in 1971 the International Committee on Taxonomy of Viruses 
(IC I'V) officially accepted Rhalidoviridae as the name for this family of viruses 
(Fenner, 1976). 
In 1963, approximately 10 years after nucleic acid was proven to be the 
hereditary chemical of life, it was shown that the nucleic acid component of VSV was 3 
sensitive to both alkali and ribonuclease digestion, thus suggesting that the hereditary 
component of VSV was RNA (Prevec & Whitmore, 1963). Subsequently, in 1966 it 
was determined that, unlike some viruses, the RNA from VSV was not by itself 
infectious (Huang & Wagner, 1966). Finally, in 1968, it was shown that the RNA 
extracted from viral genomes was complementary to viral messenger RNA (Schaffer 
et al., 1968), thus proving that rhabdoviruses were negative-stranded RNA viruses. 
A debate ensued over whether the rhabdovirus RNA was segmented or 
unsegmented, but by the early 70s, significant evidence had accumulated that the 
genome was indeed nonsegmented (reviewed in Bishop, 1979). 
The most recent significant steps in the study of Rhabdoviruses helped make 
the viruses into fully utilized tools of molecular biology. In 1981, a paper reporting 
the first full-length messenger RNAs from VSV-Indiana strain (VSV-IN) was 
published (Rose & Gallione, 1981). In 1984, exactly 100 years after Pasteur first 
alluded in his paper to rabies as a virus, the sequence of the entire VSV genome was 
published (Schubert et al., 1984). Finally, in 1994, after nearly 50 years of taking 
the back seat to VSV, the rabies virus was the first rhabdovirus to be reconstituted 
entirely from cDNA clones (Schnell etal., 1994). 
Novirhabdovirus History 
The genus Novirhabdovirus is a group of fish viruses recently recognized as 
a separate genus in the family Rhabdoviridae. There are currently three viruses in 
this family: viral hemorrhagic septicemia virus (VHSV), infectious hematopoietic 
necrosis virus (1HNV), and hirame rhabdovirus (HIRRV). 
VHSV has the longest history among the Novirhabdoviruses with reports of 
the disease, VHS, dating back to 1938 in Germany. Diseases similar in nature were 
also described in Denmark and France, and as a result there were several names for 
this disease including Infectiose Nierenschwellung and Leberdegeneration (German 
for "infectious kidney swelling and liver degeneration"), Egtved virus, pernicious 
anemia, and popeye sickness. Although tissue samples of early outbreaks were not 
saved, all of these diseases are believed to have been caused by VHSV (Post, 1987). 
The geographic distribution of VHSV was assumed to be restricted to Europe, but 
recent studies revealed that the virus also exists in wild fish populations in 4 
Washington, USA. While these isolates were originally suspected of having resulted 
from the introduction of European VHSV into the US and Canadian fisheries, 
phylogenetic analysis has shown that the North American isolates are not of 
European origin (Oshima etal., 1993). 
VHSV is primarily a pathogen of rainbow trout, although it is capable of 
infecting other salmonid fish. The optimal replication temperature for VHSV is 14­
16 °C, and it shows extreme sensitivity to warmer temperatures. Some characteristics 
of VHSV infection include darkened skin, bulging eyeballs and abdomen, 
hemorrhages in the muscle, liver, and other organs, and swollen kidneys and spleen 
(Post, 1987). 
Infectious hematopoietic necrosis virus (IHNV) infection was first reported in 
Washington, USA in 1953 (Rucker etal.,  1953). As with VHSV, the same disease 
was seen in distinct regions, including California, Oregon, and Alaska, and each 
isolation was also assigned a different name. It was only after EM images revealed 
that the various viruses had similar morphologies that Amend and Chambers (1970) 
proposed that they all be referred to as one virus. It is well established that IHNV is 
indigenous to the Pacific Northwest, but as a result of the transport of infected fish 
and eggs, outbreaks of IHNV have now been reported in Asia, Europe, and Australia 
(Nichol etal.,  1995, Post, 1987). 
IHNV can infect most salmonid fish, though it is most prevalent in chinook 
salmon, sockeye salmon, and rainbow trout. The optimal replication temperature for 
IHNV is 13-18°C. The characteristics of an IHNV infection are very to those of a 
VHSV infection, most notably darkened skin color, feeble swimming, and bloated 
abdomen (Post, 1987). 
The first record of hirame rhabdovirus (HIRRV) occurred in 1984 in cultured 
hirame (Japanese flounder) in Japan. As this is a recently described virus, its 
geographic distribution is unknown. Although infectivity studies have been 
attempted with several salmonid fish, only rainbow trout appear susceptible. The 
optimal replication temperature for HIRRV is 5-20°C.  Clinical signs include 
congested gonads, focal hemorrhage of the skeletal muscle, and accumulation of 
ascitic fluid (Kimura etal.,  1986). 
VHSV and IHNV were originally classified as members of the Lyssavirus 
genus of the Rhabdoviridae family based on similarities in protein profiles (Hill, 
1975, McAllister & Wagner, 1975). Another feature shared by Lyssaviruses and 5 
Novirhabdoviruses, although not included as a feature in their classification, is their 
apparent lack of intermediate hosts.  As more was learned about the 
Novirhabdoviruses and the first sequence information was available, it became clear 
that these viruses were quite distinct from both the Lyssaviruses and the 
Vesiculoviruses. A sixth mRNA encoding a non-virion (NV) protein was first 
discovered in IHNV and subsequently found in VHSV and HIRRV (Kurath & 
Leong, 1985, Schutze et al., 1996). This extra gene distinguished this group of 
viruses and led to its classification as the genus Novirhabdovirus (after the NV 
gene). 
Snake head Rhabdovirus (SHRV) 
Snakehead rhabdovirus (SHRV) is an aquatic warmwater rhabdovirus, 
isolated from a diseased snakehead fish (Ophicephalus struatus) during an epizootic 
outbreak in Thailand (Kasornchandra et al.,  1992b). The disease caused 
characteristic necrotic ulcerations and was observed in both wild and pond-cultured 
fish throughout southeast Asia (Kasornchandra et al., 1991). Although several fish 
species were affected by the disease, it most often appeared in the cultured snakehead 
(Ophicephalus struatus), the walking catfish (Cktrias bratachus), and the sand goby 
(Oxyeleotis rnarmoratus). SHRV was one of several pathogens (viral, bacterial, 
protozoan, and fungal) associated with this ulcerative disease (Boonyaratpalin, 1989; 
Frerichs et al., 1986; Hedrick et al., 1986; Kasornchandra et al., 1992b; 
Wattanavijarn et al., 1986). It has not been established whether or not a single 
etiologic agent was responsible for the disease (Hedrick et al., 1986).  Initial 
characterization of SHRV using electron microscopy, cross-neutralization tests, and 
protein electrophoresis profiles indicated that SHRV was a unique rhabdovirus with 
characteristic bacilliform morphology and a protein expression pattern most similar to 
the Novirhabdoviruses VHSV, IHNV, and HIRRV (Kasornchandra et al., 1992b). 
Biological characterization of SHRV revealed that optimum replication 
occurred between 24-30°C, but the virus could tolerate temperatures as high as 350C. 
Growth studies showed that SHRV produced infectious particles as early as four 
hours post-infection, and the total virus titer reached 108 TCID50/mL at 12 hours 
post-infection (Kasornchandra etal., 1992a). 6 
General Biology of Rhabdoviruses 
The Virion 
The genome of rhabdoviruses is a single negative-stranded nonsegmented 
RNA molecule of approximately 11 kb. Generally, 90-95 percent of the nucleotides 
are used to encode the five proteins produced by the virus. The five proteins have 
been physically mapped on the genome ordered 3'.-5'; the nucleocapsid protein (N), 
the phosphoprotein (M1, P, or NS), the matrix protein (M or M2), the glycoprotein 
(G), and the polymerase protein (L). Although there are some minor variations 
within the rhabdovirus family regarding the number of genes expressed (as was 
observed with the Novirhabdoviruses), all Rhabdoviridae genomes contain these 
minimum five genes, and the order of these genes within the genomes is consistently 
conserved (Wagner, 1990). 
The intact rhabdoviral virion is approximately 180 nm in length and 65 nm in 
width, and usually has a distinct bullet-shaped morphology. The estimated molecular 
weight of a single VSV virion is 265 MDa with a chemical composition of 74% 
protein, 3% protein-associated carbohydrate, 20% lipid, and 1% nucleic acid 
(Thomas et al., 1985). 
The heart of the rhabdovirus virion is a single copy of the RNA genome, of 
11,162 nucleotides in the case of VSV. Closely associated with the nucleic acid are 
the viral N, P, and L proteins, which together make up the ribonucleoprotein 
complex (RNP). This complex contains all the mandatory components for viral 
transcription and replication. Thus, if the RNP is introduced into a susceptible cell, it 
can result in a productive infection, even without the other viral components present 
(Wagner, 1990). More thorough analysis of the RNP using scanning EM indicates 
in combination with biochemical quantitation revealed that the RNP contains 
approximately 1258, 466, 50, and 1 copy of N, P, L, and the RNA genome, 
respectively (Thomas et d., 1985). Listing the activities of these proteins, the N 
protein, which ranges in size from 40-60 kDa for the different rhabdoviruses, 
specifically binds the RNA molecule. The P protein, which varies between 20-45 
kDa, binds both the N protein and the L protein. The P protein, which presumably 
holds the core together, is only functional in association with the L protein. The L 
protein is the largest rhabdoviral protein, over 200 kDa in size; in combination with the P protein, it is responsible for transcription, mRNA capping, methylation, 
polyadenylation, and genomic replication (Wagner, 1990). 
Moving outward, the M protein is found between the RNP and the cellular 
envelope and is the major structural protein independently forming the viral matrix. 
The M protein is a smaller protein, 20-30 kDa in size, and has binding affinity for 
both the N protein and phosphatidylserine residues, which line the inner surface of 
the cell's plasma membrane. According to an estimation, there are 1,826 copies of 
the M protein per VSV virion (Thomas et al., 1985). 
The outer membrane of the rhabdovirus virion consists of entirely host-
synthesized lipids, but in proportions different from those of the host plasma 
membrane, with nearly twice the concentration of cholesterol and sphingomyelin, 
and only half as much phosphotidylcholine (Bishop, 1979). Protruding through the 
viral envelope is the viral G protein, which is usually 60-80 kDa. This protein is 
primarily extra-viral, with a short intracellular peptide, has multiple N-linked 
oligosaccharides, and is solely responsible for virus attachment to the host cell. 
There are an estimated 1205 copies of the G protein per VSV virion (Thomas et al. , 
1985). 
Rhabdovirus Infection 
There are five stages in a typical rhabdoviral infection: attachment and 
absorption, penetration, transcription, replication, and budding. The attachment 
stage of infection is entirely the responsibility of the viral G protein. Binding occurs 
in an energy-independent manner to a specific cellular receptor. It is still unknown 
whether there is a single viral receptor present on all cells for a particular rhabdovirus 
or whether there are several host cell surface proteins that may be used by 
rhabdoviruses to enter the cell.  If there is a single receptor, it is a relatively 
ubiquitous one as rhabdoviruses are promiscuous, often able to infect multiple cell 
types from several animal kingdoms. Following receptor binding, energy dependent 
absorption occurs.  It has been proposed that this occurs by endocytosis through 
coated pits, after which fusion with a lysosome causes a pH change and a subsequent 
conformational change in the G protein, ultimately resulting in a fusion event and 
release of the virus into the cytoplasm (Matlin et al., 1982). While not all of this 8 
staging has been proven, EM images of viral infections have revealed viral 
endocytosis through what appears to be coated pits (Mat lin et al., 1982), and viral G 
proteins have been shown to induce pH-dependent membrane fusion (Eidelman et 
al., 1984). 
Once the RNP is released into the cytoplasm, transcription begins. The RNA 
genome serves as template for seven different RNA species: a short 50 nucleotide 
leader RNA, the five different mRNA species representing the five viral proteins, and 
the full-length positive-strand genome. Transcription begins at the 3'-terminus of the 
genome, where the polymerase complex transcribes the roughly 50 nucleotide "leader 
sequence" between the terminus of the genome and the transcription start site of the 
first gene. Once the polymerase reaches the first transcriptional start site, the leader 
RNA is released and transcription of the first mRNA begins. The leader RNA is 
neither capped nor polyadenylated. While there is some evidence that the leader 
RNA can inhibit host transcription, no definite function has been identified for the 
leader RNA. Transcription of the first gene (N) proceeds until it reaches the 
intergenic polyadenylation sequence, at which point the mRNA is polyadenylated and 
released, and the polymerase complex begins transcription of the next mRNA, whose 
transcriptional start is generally two nucleotides past the end of the polyadenylation 
sequence. Transcription proceeds down the genome, and because not all termination 
events are followed by reinitiation, there is progressively less of each mRNA. 
Consequently, there is quantitatively more N mRNA than P mRNA, more P mRNA 
than M mRNA, and so forth (Wagner, 1990). 
At some point during the infection, the polymerase switches from 
transcription mode to replication mode, at which point it no longer stops at the 
transcriptional stop/polyadenylation sequence but rather continues transcription to 
produce a full-length anti-genomic (positive-stranded) RNA. The dynamics of the 
switch to replication are not entirely understood, but it is believed that when the 
intracellular concentration of the N protein is sufficiently high, the newly synthesized 
N protein binds to nascent RNA and serves as an anti-terminator (Wagner, 1990). 
Once the anti-genomic RNA is produced, its sole role is to serve as template for new 
negative-stranded genomes. Replication of the positive strand occurs in the same 
way as the negative strand, except that there are no transcriptional stop sites in the 
reverse orientation, and hence, only full-length copies are produced. 9 
The final stage of infection is the virion assembly and budding. The RNA is 
coiled with the N protein and the RNP is held together by the P protein. The RNP is 
encapsulated in the M protein as it buds from the plasma membrane (Newcomb & 
Brown, 1981). The M protein has binding sites for both the plasma membrane and 
the N protein and is the only mandatory protein for budding, although budding is 
greatly enhanced when the G protein is present. The G protein, which is the only 
viral protein processed through the endoplasmic reticulum, is transported to the 
plasma membrane as a transmembrane protein. The cytoplasmic tail of the G protein 
interacts with the M protein, but the interaction is entirely sequence-independent, and 
just three amino acids are adequate for proper assembly (Mebatsion et d., 1999, 
Schnell etal., 1998). 
Viral Reverse Genetics 
History of Recombinant Viruses 
Genetics is defined as "the study of heredity," and heredity is defined as "a 
familial phenomenon wherein biological traits appear to be transmitted from one 
generation to another" (King & Stansfield, 1990).  Genetics always begins by 
observing a phenotype and involves the study of the genotype responsible for that 
phenotype. Consequently, the term "reverse genetics" describes experiments which 
follow the opposite process: starting with a genotype, making alterations, and 
observing the phenotype. Successful reverse genetics experiments with viruses 
entail the isolation of a virus' nucleic acid genome, the alteration of this nucleic acid, 
and then the recovery of viable virus from the altered nucleic acid. 
The ability to recover viable virus from raw nucleic acid is not a recent 
scientific achievement.  In 1952, two scientists showed that the nucleic acid 
component from bacteriophage was the necessary substance for producing a viral 
infection. This experiment was the first step towards viral reverse genetics, but most 
biologists remember it because it proved that nucleic acid and not protein is the 
hereditary chemical in biology (Hershey & Chase, 1952). While this experiment was 
performed with only partially purified nucleic acid, purified RNA from tobacco 10 
mosaic virus was shown to be infectious in 1956 (Gierer & Schramm, 1956), as was 
Mengo encephalitis RNA in 1957 (Colter etal., 1957). 
With the ability to recover live virus from nucleic acid, much experimentation 
was done with how to introduce viral DNA into cells most efficiently. In fact, this is 
why the word transfection, which is defined as "to infect with the nucleic acid of a 
virus so as to cause the cell to produce the virus" (Barnhart, 1986), has come to 
simply mean the introduction of DNA into cells. The transition from recovering 
infectious virus using nucleic acid to performing true reverse genetics occurred 
slowly as the tools developed for manipulating DNA, but by 1979 scientists were 
able to manipulate DNA viruses such that they could be used as eukaryotic 
expression vectors (Mulligan eta, 1979). 
The breakthrough with positive-stranded RNA genomes came in 1978 when 
RNA phage QI3 was recovered from a complete DNA copy of its genome, which was 
cloned into a plasmid vector (Taniguchi et al., 1978).  Three years later, the 
experiment was successfully replicated with the cloned cDNA from poliovirus 
(Racaniello & Baltimore, 1981).  These accomplishments opened the door for 
reverse genetics to be performed on almost any positive-stranded RNA virus. 
By 1981, essentially the only virus types which could not be genetically 
manipulated were the viruses lacking infectious nucleic acids. Some viral genomes, 
both from RNA and DNA viruses, do not have infectious genomes because they use 
their own enzymes for transcription and replication. For these viruses, the genome is 
only infectious if viral proteins are also present to jump start the infection. Among 
the viruses which fit into this category are all of the negative-stranded RNA viruses, 
such as rhabdoviruses, and many of the more complex DNA viruses, such as pox 
viruses. The breakthrough with vaccinia virus came in 1982 when a system was 
developed which introduced changes in vivo by selecting for homologous 
recombination events (Mackett et al., 1982). Similar strategies soon followed for 
other DNA viruses with non-infectious genomes. 
Between 1978 and 1982, reverse genetics had become a reality for most of 
the major virus families, yet it took another 12 years before it could be performed on 
negative-stranded RNA genomes. 11 
Recombinant Negative-Stranded Viruses 
The first partial recombinant negative-stranded RNA virus was produced in 
1989 when the influenza virus was induced to replicate and incorporate an extra RNA 
segment containing a reporter gene (Luytjes etal., 1989). While this was technically 
a recombinant virus, the process was not truly reverse genetics as the experiment 
required starting with live virus, and it did not modify the existing genome. In 1990, 
scientists working with influenza achieved partial reverse genetics when researchers 
replaced one of influenza's genes with a recombinant gene. However, the system 
was limited because it required starting with a live virus defective in the gene to be 
replaced (Enami et al., 1990). 
In order for complete reverse genetics to become a possibility, researchers 
had to essentially replicate all of the components of a viral infection and create a 
minimum infectious unit. In the case of VSV, a minimum infectious unit consists of 
a full-length copy of its genome, 1200 copies of its nucleocapsid protein, 400 copies 
of its phosphoprotein, and 50 copies of its L protein (Thomas et al., 1985). 
Producing N, P and L was not difficult since the proteins could be expressed 
independently or they could be provided by a helper virus; providing a full-length 
copy of an RNA genome was somewhat trickier. Rather than produce such a large 
RNA in vitro, the strategy used was to transcribe the RNA in the cytoplasm of a 
permissive cell under the control of T7 RNA polymerase. Because the promoter for 
T7 RNA polymerase is a short nucleotide sequence with a well defined start site, it 
was possible to engineer the promoter such that the first nucleotide transcribed was 
the first nucleotide of the genome. The problem of how to introduce the T7 RNA 
polymerase into the cytoplasm of a cell was solved by using another recombinant 
virus. Cells were pre-infected with a recombinant vaccinia virus which was designed 
to overexpress T7 (Fuerst et al., 1986). Finally, while the T7 RNA polymerase 
produced the correct terminus at one end of the genome, a method still had to be 
developed for having the RNA molecule end at the last nucleotide of the genome. 
This problem was solved by having the sequence immediately following the genome 
termini encode a ribozyme sequence from hepatitis delta virus, which cleaves itself at 
a specific site to liberate the full-length genome (Perrotta & Been, 1991). With the 
whole scheme worked out, scientists were able to induce replication of a truncated 
viral genome by coexpressing the three viral proteins required for replication with the 12 
truncated genome (Conzelmann & Schnell, 1994, Pattnaik et al., 1992), yet every 
attempt at producing a recombinant virus using the full-length genome ended in 
failure. 
The final breakthrough came in 1994, when researchers working with rabies 
virus changed one obscure point of the experiment, which was to express a positive-
strand copy of the genome instead of a negative-strand copy. With this change, the 
first recombinant rabies virus was produced in 1994 (Schnell et al., 1994), and 
within a year the experiment was duplicated by two groups working with VSV 
(Lawson etal., 1995, Whelan etal., 1995). Theoretically, either a positive-strand or 
a negative-strand genome could serve to begin an infection. One would think that the 
negative strand would be more efficient both because it mimics what happens during 
a natural infection, and because it can serve directly as the mRNA template. 
However, only experiments using the positive strand have been successful. There 
are two theories to explain the failure of the negative-stranded RNAs. The first 
theory suggests that the transcriptional stop site/polyadenylation site for 
rhabdoviruses, when read in the reverse orientation, is somewhat similar to the 
transcriptional stop site of T7 polymerase, which would mean that no full-length 
genomic transcripts are produced when the negative strand is produced by T7 
(Lawson et al., 1995, Whelan et al., 1995). The second theory notes that since 
mRNA from the three viral proteins would be complementary to the negative-sense 
genome, RNA/RNA hybridization could inhibit the infection (Schnell etal., 1994). 
Progress from Recombinants 
The first report of a recombinant rhabdovirus now lies almost five years in 
the past. In justification of the usefulness of reverse genetics in viral study, I will 
now review a portion of the findings, from both basic research and applied research, 
which have arisen directly from the ability to perform reverse genetics on negative-
stranded RNA viruses. 13 
Extra Genes 
Some rabies virus strains contain a "pseudogene" between their G and L 
genes.  To address the function of this "pseudogene", recombinant viruses were 
produced which lacked this gene, and the recombinants were found to be identical to 
wild type virus in replication and infectivity (Schnell et al., 1994). Similarly, VSV 
genomes contain two small open reading frames (ORFs) within the viral P gene, but 
altering of the genome such that these ORFs could not be expressed resulted in no 
noticeable alterations in the virus (Kretzschmar et al., 1996).  Neither of these 
examples proves that the extra genes are without function; they only prove that these 
"genes" are not required for replication in cell culture. 
Budding 
Prior to 1994, it was not entirely clear which viral proteins were required for 
successful budding in rhabdoviruses. With reverse genetics, viruses were created 
which entirely lacked a viral G protein (Mebatsion et al., 1996a) or the M protein 
(Mebatsion et al., 1999). The viruses lacking the G protein were still able to undergo 
normal budding and produce the characteristic bullet shape, but the frequency of 
budding events was reduced by 30-fold compared to wild-type virus. In viruses 
lacking the M protein, there was limited budding, and the particles produced were not 
bullet-shaped. Moreover, while there is usually association between viral G protein 
and the RNP, no interaction was seen between these two entities in the viruses 
lacking the M protein. Collectively, this data was interpreted to mean that the M 
protein and the G protein have both independent and cooperative budding functions. 
Further, the interaction between the G protein and the rest of the viral components 
occurs through the M protein. In a separate experiment, it was shown that the 
cytoplasmic tail of the G protein could be replaced with a random sequence as short 
as three amino acids in length without affecting viral budding, indicating that the G 
protein/M protein interaction is not sequence-specific (Johnson et al., 1999, Schnell 
et al., 1998). 14 
Transcription 
A number of papers have been published specifically analyzing the cis-acting 
signals required for transcription termination, polyadenylation, and transcriptional 
initiation (Barr eta, 1997a, Barr etal., 1997b, Hwang etal., 1998, Schnell etal. , 
1996, Stillman & Whitt, 1997, Stillman & Whitt, 1998).  Despite the nearly 
exhaustive mutagenesis which has been performed  on the intergenic region 
responsible for these tasks, no single model for how the three events occur has been 
agreed upon. There are several points, however, on which scientists agree: in the 
genome there is a highly conserved 23 nucleotide domain, which is solely 
responsible for signaling all three transcription events; the first 13 nucleotides of this 
sequence are sufficient to signal termination and polyadenylation; and the site of 
transcriptional initiation is affected by both nucleotide consensus sequence and 
proximity to polyadenylation sequence. 
Vaccine Development 
With both rabies and VSV it has been shown that additional genes could be 
inserted and expressed using the minimal transcriptional signals (Mebatsion et al.  , 
1996b, Rolls etal., 1996, Schnell et ad., 1996). This information was utilized to 
develop a VSV virus which expressed the hemagglutinin (HA) gene from influenza 
virus (Kretzschmar et all, 1997). This VSV virus was subsequently used as an 
attenuated vaccine against influenza. Mice which were vaccinated with this virus 
intranasally produced neutralizing antibodies against HA and were 100% protected in 
a subsequent influenza challenge (Roberts etal., 1998). 
Anti-AIDS Virus 
One of the most interesting avenues of research evolving from the reverse 
genetics work is the construction of recombinant viruses which selectively kill HIV-
infected cells. HIV specifically infects CD4T cells by a well characterized interaction 
between the viral gp120/41 envelope protein and the CD4 receptor followed by the 15 
coreceptor CXCR3, CCR5, or CCR3. VSV and rabies recombinant viruses have 
been engineered with CD4 and CXCR3 envelope proteins instead of the G proteins. 
These recombinant viruses have been shown to infect only cells which are expressing 
HIV envelope gp120/41, thus they infect only HIV-infected cells (Mebatsion et al. , 
1997, Schnell et al., 1997). The infection of HIV-infected cells with the VSV 
recombinant resulted in the killing of the HIV-infected cells, and ultimately there was 
a 104-fold reduction in HIV virus production. These types of vectors show great 
promise as a potential therapeutic agent against HIV infection. 
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Abstract 
We have determined the complete coding sequences for the glycoprotein (G) 
genes from two rhabdoviruses that infect warmwater aquatic animals, the snakehead 
rhabdovirus (SHRV) and rhabdovirus of penaeid shrimp (RPS). To our surprise, 
the G nucleotide sequence from RPS, a virus which has been isolated from diseased 
shrimp in Hawaii on numerous occasions, was over 99% identical to the G 
nucleotide sequence from spring viremia of carp virus (SVCV), a fish virus from 
Europe. This is the first report of SVCV isolation outside of Europe and Asia, and it 
is also the first report of SVCV infecting a non-vertebrate species. The G gene from 
SHRV was most closely related to the G genes from the three Novirhabdoviruses, 
viral hemorrhagic septicemia virus (VHSV), infectious hematopoietic necrosis virus 
(IHNV), and hirame rhabdovirus (HIRRV), with 47 %©, 37%, and 36% amino acid 
identity, respectively. In addition, a phylogenetic analysis performed using the 
amino acid sequence from rhabdoviral G genes indicated that SHRV groups within 
the Novirhabdovirus genus. Finally, the SHRV-G gene was successfully expressed 
in mammalian cells under the control of the cytomegalovirus (CMV) promoter, 
establishing that it is a suitable gene for use in the production of fish-specific 
pseudotyped retroviruses. 
Introduction 
Snakehead rhabdovirus (SHRV) and rhabdovirus of penaeid shrimp (RPS) 
are members of the family Rhabdoviridae and both infect warmwater aquatic animals. 
SHRV was isolated from a diseased snakehead fish (Ophicephalus struatus) during 
an epizootic outbreak in Thailand. The disease caused characteristic necrotic 
ulcerations in both wild and pond-cultured fish throughout southeast Asia 
(Kasornchandra et al., 1991). Although several fish species were affected by the 
disease, it was most noted in the cultured snakehead (Ophicephalus struatus), the 
walking catfish (Clarias bratachus), and the sand goby (Oxyeleotis marmoratus) 
(Hedrick et al., 1986). SHRV was one of several pathogens (viral, bacterial, 
protozoan, and fungal) associated with this ulcerative disease (Boonyaratpalin, 1989; 
Frerichs et al., 1986; Hedrick et al., 1986; Kasornchandra et al., 1992b; 23 
Wattanavijarn et al., 1986) and efforts to identify a single etiologic agent for the 
disease have produced equivocal results  (Hedrick et al.,  1986).  Initial 
characterization of SHRV using electron microscopy, cross-neutralization tests, and 
protein electrophoresis profiles indicated that it was a unique rhabdovirus with 
characteristic bacilliform morphology and a protein expression pattern most similar to 
the members of the genus Novirhabdoviruses.  This genus includes viral 
haemorrhagic septicemia virus (VHSV), infectious hematopoietic necrosis virus 
(IHNV) and hirame rhabdovirus (I -BRRV) (Kasornchandra et al., 1992b). 
Rhabdovirus of penaeid shrimp was isolated from two species of diseased 
penaeid shrimp (Penaeus stylirostris and Penaeus vannamei) obtained from three 
different shrimp farms in Hawaii (Lu et al., 1991).  Initial electron-microscopy 
studies revealed that RPS had bullet-shaped particles characteristic of a rhabdovirus 
(Lu et al., 1991). Infectivity studies of this virus in young shrimp (P. stylirostris, 
0.2 g), through water-borne, oral feeding, and intramuscular injection, showed that 
the virus both replicated in the shrimp and caused significant mortalities (Lu and Loh, 
1994). Serological studies with this virus indicated that RPS was serologically 
related to spring viremia of carp virus (SVCV) (Lu et al., 1994). 
Our motivation for sequencing the G genes from these two rhabdoviruses 
was two-fold. First, the sequences in themselves would prove immediately useful 
both in determining the phylogenetic relationship of the viruses to other 
rhabdoviruses and in developing molecular diagnostic tools. Second, the G genes 
could prove useful in engineering fish-specific pseudotyped retroviruses. A 
pseudotyped retrovirus is a chimeric virus which contains the retroviral genome, 
capsid, replication, and integration proteins packaged in the envelope of a 
heterologous virus (Emi et al., 1991). These viruses have been used to deliver DNA 
into live cells for gene therapy and for the production of transgenic animals. 
Pseudotyped retroviruses as a result of the incorporation of rhabdoviral G proteins 
into its envelope have a much broader host range and are able to efficiently integrate 
its genome into the genome of its host (Burns et al., 1993). One such pseudotyped 
retrovirus, which contained the retroviral proteins from Moloney murine leukemia 
virus (MoMLV) packaged in the G protein from vesicular stomatitis virus (VSV), 
was able to infect both mammalian and, to a much lower extent, salmonid and 
zebrafish cells (Lin et al., 1994). Our intent was to use the G proteins described in 24 
this paper to produce pseudotyped retroviruses specifically  designed to infect 
warmwater fish and shellfish. 
We have determined the nucleotide  sequences from the warmwater 
rhabdoviral G genes of SHRV and RPS. Using this  sequence data, we have 
determined the phylogenetic relationship of these G genes to those of the other 
rhabdoviruses. With SHRV, we have further expressed the G gene in vitro, and in 
mammalian tissue culture cells in preparation for its use in the production of a fish-
specific pseudotyped retrovirus. 
Materials and Methods 
Cells and Viruses 
Epithelioma papulosum cyprini (EPC) cells were used for propagation of 
both viruses (Fijan et al., 1983). The cells were grown at room temperature in 
minimal essential medium (MEM) supplemented with 10% fetal calf serum and 2mM 
L-glutamine. RPS was obtained from diseased shrimp in Hawaii (Lu et al., 1991). 
The snakehead rhabdovirus (SHRV)(Kasornchandra et al., 1992b)  was obtained 
from Dr. John Fryer, Oregon State University. EPC cells were infected with RPS or 
SHRV at a multiplicity of infection of 0.5 and incubated at room temperature until 
70% of the cells exhibited a cytopathic effect (1-2 days). The infected cells were 
collected and used for subsequent RNA purification. 
Transfections were performed using baby hamster kidney cells (BHKs). The 
cells were grown at 37°C in Dulbecco's modified Eagle's Medium (DMEM) 
supplemented with 10% fetal calf serum. 
RNA Purification 
Total cellular RNA was extracted from infected cells with RNAzol (Tel-Test, 
Inc., Friendswood, TX) according to the manufacturer's instructions. Messenger 
RNA was separated from the RNA preparation using an Oligotex mRNA kit (Qiagen, 
Palo Alto, CA). 25 
RACE-PCR 
The SHRV glycoprotein (SHRV-G)  sequence was obtained by modified 
versions of the 5' and 3' rapid amplification of cDNA ends (RACE) protocol 
(Frohman, 1990). For 3' RACE reactions, 1 mg of the polyA RNA preparation was 
mixed  with  50  pmoles  primer  ME  102  (5'­
GACTCGAGTCGACATCGA'nTrrriTiTiTriTrr-3'), 20 nmoles dNTP, 4µL 
5X AMV-RT buffer, 10 units RNasin (Promega, Madison, WI) and 10 units AMV­
RT (Reverse Transcriptase, Promega) in a total volume of 20 ILL and incubated for 1 
h at 42°C, followed by 52°C for 30 minutes. Following reverse transcription, the 
cDNA was mixed with 900 ILL H2O and 1µL from the cDNA reaction mixture was 
used as template for each of the PCR amplifications. PCR reactions contained: 1X 
PCR buffer, 1.5 mM MgC12, 200 ILM dNTP, 20 pmoles ME 108 (5'­
GACTCGAGTCGACATCG-3'), 20  pmoles  ME  125  ( 5 '­
TGGATGACTTTGCCTATC-3'), 1 ILL cDNA, and 2 units Taq polymerise 
(Promega). PCR amplifications were performed in an Amplitron II programmable 
heating block (BarnsteadiThermolyne, Dubuque, IA) using the followingparameters: 
three low temperature annealing cycles of 30sec at 94°C, 45 sec at 42°C, and 2 min 
at 72°C, followed by thirty cycles of higher temperature annealing that included 30 
sec at 94°C, 45 sec at 45°C, and 2 min at 72°C. 
For 5' RACE, reverse transcription was carried out as previously described 
with the exception that the primer ME 325 (5'-TGATGGGGCCTGAGTGACC-3') 
was used. Following reverse transcription, cDNA was concentrated and primer 
removed using a Centricon 100 spin column (Amicon, Inc., Beverly, MA). The 
concentrated cDNA was then treated with terminal transferase to add a 3' polyA tail 
as follows: cDNA was mixed with 4 pi. of 1 mM dATP, 1 FLL TdT (Terminal 
Transferase, Promega) and 4 }IL of TdT 5X buffer in a final volume of 20 ILL and 
incubated at 37°C for 10 minutes, followed by 90°C for 2 minutes. Following 
tailing, the cDNA was diluted to 500 ILL in water and 1 ILL was used in subsequent 
PCR reactions. The amplification reactions contained the same ingredients as 3' 
RACE except primers ME 102, ME 108,  and ME 324  (5'­
CCATGTTAACAATTGCGTGGTTCAG-3') were used.  For 5' RACE the 
following parameters were used: forty cycles of 40 sec at 95°C, 40 sec at 50°C, and 
3 min at 720C. 26 
The PCR products were separated by electrophoresis in a 1% agarose gel and
 
bands containing cDNA of the appropriate size were excised. The PCR amplified
 
cDNA was extracted and subcloned into a TA cloning vector pCR2.1 using the
 
manufacturer's instructions (InVitrogen, San Diego, CA).
 
Full-length SHRV-G Clone 
Once the full-length sequence of SHRV-G was known, three full-length 
clones were generated by separate amplification reactions using two gene-specific 
primers. To avoid PCR error, all three clones were sequenced and a consensus 
sequence was determined. A single correct clone was created by cutting and pasting 
together error-free regions of the clones. The error-free G clone was then subcloned 
into eukaryotic expression vector pcDNA3 (InVitrogen), creating vector pcDNA3­
SFIRV-G. 
Library Preparation 
A cDNA expression library of RPS was constructed using the ZAP 
ExpressTM cDNA Synthesis kit and ZAP ExpressTM Gigapack II Gold cloning kit, 
using the manufacturer's instructions (Stratagene, La Jolla, CA).  Following 
construction, 20 clones were sequenced at random. 
Sequence Analysis 
All DNA sequence analyses were performed by the Oregon State University 
Center for Gene Research and Biotechnology Central Services Facility  on a 373 
DNA sequencer (DuPont Applied Biosystems, Boston, MA). 
The amino acid sequenceS of the G proteins  were deduced using the 
sequence editor of GCG (Wisconsin Package Version 9.1, Genetics Computer 
Group, Madison, WI). Sequences were aligned at the amino acid level initially using 
the results of individual gapped BLASTP (version 2.0) searches (Altschul  et al., 27 
1997), after which the pairwise alignments were adjusted by hand to create a 
consensus alignment. A phylogenetic tree was created using 203 of the highly 
conserved amino acid positions with the neighbor-joining program (GCG). The 
sequence data was bootstrapped 100 times using the program seqboot (GCG) and the 
bootstrapped data were analyzed with the programs protdist (GCG) and protpars 
(GCG). 
InVitro Translation 
lnvitro translations were performed using the TINfr Coupled Reticulocyte 
Lysate System according to the manufacturer's instructions (Promega).  Briefly, 
12.5 uL TNT Rabbit Reticulocyte Lysate, 1 pt TNT reaction buffer, 0.5 RI, T7 RNA 
polymerase, 0.5 pL 1mM amino acid mixture minus methionine, 2 !IL 35S 
methionine (1000Cihrunol) (Dupont NEN, Minneapolis, MN), 0.5 pL RNasin, and 
0.5 )ig plasmid DNA were mixed in a final volume of 25 RI, and incubated at 30°C 
for 2 hours. Two tAL of each sample were mixed with 81AL of SDS-PAGE reducing 
loading buffer and heated to 100°C for 2 minutes. The samples were then loaded 
onto a 12.5% SDS-PAGE with a 5% stacker, and run at 100 V. The gel was dried 
under vacuum and exposed on X-omat blue XB-1 film (Kodak, Rochester, NY). 
Transfection and lmmunohistochemistry 
Transfections were performed in baby hamster kidney (BHK) tissue culture 
cells with Lipofectamine Plus transfection reagent using the manufacturer's 
instructions (Life Technologies, Gaithersburg, MD). BHK cells were transfected 
either with plasmid pcDNA3-SHRV-G, or pcDNA3-SHRV-N, a vector with an 
identical vector backbone but containing the nucleocapsid protein from SHRV. The 
transfection medium was removed one day after transfection and replaced with 
regular growth medium. Two days after the transfection the cells were washed once 
with phosphate buffered saline pH 7.6 (PBS), fixed with 3.7% formaldehyde in 
PBS for 15 minutes, and washed 5 times with PBS. Monoclonal antibody A-9H 
(Kasomchandra et al., 1992b) was applied to the cells and incubated for 1 hour, then 28 
rinsed.  Cells were then stained using the Vectastain ABC kit and Alkaline 




The SHRV-G gene sequence was obtained using a modified RACE 
procedure (Frohman, 1990). Initially, mRNA was reverse transcribed with RACE 
primer (ME 102) and amplification reactions were performed using the second RACE 
primer (ME 108) and one of a series of forward primers designed to the G gene of 
IHNV. Our hope was that there would be enough sequence conservation between 
SHRV and IHNV that one of these primers would amplify SHRV cDNA. Of the six 
primers that were used, only one (ME 125) proved successful in amplifying 700 base 
pairs of the 3' end of SHRV-G (Fig. 2.1).  It was later realized that ME 125 was 
homologous at 16/18 positions. The 5' end of SHRV-G was obtained by 5' RACE 
as follows: SHRV cDNA was first prepared using a SHRV specific reverse primer 
(ME 325) from within the 700 base pairs, after which the cDNA was polyA tailed at 
the 5' end and PCR was performed with the two RACE primers (ME 102 and ME 
108) and a second SHRV specific primer (ME 324). 
Once the entire sequence of SHRV-G was known, three full-length clones 
were PCR amplified using SHRV-G specific primers. The PCR amplified DNA was 
subcloned into vector pCR2.1 and sequenced. The sequence data were used to 
determine the G consensus sequence and subsequently, an error-free clone was 
created by cutting and pasting together error-free regions of the three clones. Finally, 
the full-length error-free clone was subcloned into the eukaryotic expression vector 
pcDNA3. 29 
5' RACE-PCR 
ME 102  ME 125 SHRV-G  poly A tail 
VISMINM. 
poly A tail 
ME 524  ME 525  ME 102 
3' RACE-PCR 
Fig. 2.1. Schematic of RACE PCRs. 30 
RPS-G Cloning 
All of our attempts to clone parts of RPS-G using IHNV primers in RACE 
PCR reactions failed. Instead, a cDNA library was constructed using the lambda Zap 
Express Ism kit using polyT primers. Random sequencing of 20 clones from this 
cDNA library revealed that approximately 80% of the clones were viral genes 
including M, N and P. One of the 20 clones was the RPS-G gene. 
Sequence Analysis 
Initial characterization of cDNA clones was achieved by performing gapped 
BLASTN and BLASTX searches (Altschul et al., 1997). Surprisingly, the sequence 
from RPS was found to be nearly identical to that of spring viremia of carp virus 
(SVCV). The predicted amino acid sequence of RPS-G was identical at 506/509 
positions and 504/509 positions with the two SVCV-G sequences in Genbank (Fig. 
2.2). The nucleotide sequence from the open reading frame of RPS-G was identical 
to the sequences SVCV1 and SVCV2 at 1526/1530 and 1517/1530 positions, 
respectively (data not shown). Partial sequence from the phosphoprotein gene (P or 
MI) and the matrix protein gene (M or M2) were also found to be identical or nearly 
identical to the sequences from SVCV (data not shown). Because the glycoprotein 
from SVCV has been characterized previously (Bjorklund et al., 19%), no additional 
analyses of the RPS-G was carried out. However, RPS (SVCV) specific primers 
were designed and used to detect viral sequences directly in diseased shrimp tissue. 
Blast searches performed with the predicted amino acid sequence from 
SHRV-G revealed that this sequence was most closely related to the G protein from 
VHSV, a member of the rhabdoviral genus Novirhabdovirus (Fig. 2.3). The G gene 
encoded two potential start codons, neither of which was particularly similar to the 
Kozak consensus sequence (Kozak, 1987)(data not shown). The protein shown in 
Fig. 2.3 was translated from the first potential start codon. SHRV-G was found to 
possess 47%, 37%, and 36% amino acid identity with VHSV-G, IHNV-G, and 
HIRRV-G, respectively. All 12 of the cysteines known to be involved in disulfide 
binding in VHSV (Einer-Jensen et al, 1998), are conserved among all 4 viruses. In 
addition, the glutamine which was shown to be the site of cleavage in VHSV-G 31 
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Fig.  2.2.  RPS/SVCV alignment.  Alignment of deduced amino acid
 
sequences of the G proteins of rhabdovirus of penaeid shrimp (RPS)
 
and the two reported sequences of SVCV (SVCV1, Rossius, unpublished;
 
1072745, and SVCV2, ((Ejorkiund et al., 1996)  1066018). The symbol
 
(.) indicates the amino acid is identical to that of RPS.  Numbers in
 





VHSV M  ECNTFFL.I.IIIIKSTTS.I.OR.PVENIST.HAD.DT.L..H..NCRIM  52
 
IHNV M  DTMITTPLILI.ITCGA.S  -.v..DTA.ESD -QPT.S..LF.Y.EG.TLD  51
 
HIRRV M  DP RIMYYT.L.TTAARVYG-.-.I..GVD.VSD-QPT.A..LF.Y.VD.PAA  51
 
SHRV TFAPVKPEKLRCPHIFDDQNLGLTASKAKILHMDLKPEDTHFEAKGRLIAKVTYQVLCS  116
 




HIRRV KLSKVS.S0....RI...E.Q..V.YP.V.RSLSVGNNLGDIHTQ.EYV...L.RTT..  110
 
SHRV TGFFGGRTVTRIKVLETPMGDNEAQAYKAVDREFPYFPEPLCFWLRMAAERVFHFSTP  175
 
VHSV  .S....Q.IEKTI..AXLSRQ..TNEAGK.H.Y.F....SCI.MK...HKDITHyMp  170
 
IHNV  Q IEKALV.mmiSTK..0..DTTTAAAL...A.R.Q.YT...QNDLI.YYT.Q  169
 
HIRRV  Q.IEKALV.MKLAPR.VGVYDTTTASAL...A.R.Q.YT...HNDLT.YYT.A  169
 
SHRV KTvTvuysmaispDFVGGWAKSPCPTHWpNVYWVGETQSPECPSIDTEGGHIrTAK  234
 
VHSV  ...SI  FLN...IE.VCTT..C....W...I.A.PQAHC.TSE.LK..L..RT  229
 
IHNV  .S.LR.p.T.DFLDS..I..K.T....Q...S..V.M.DAGIPA.D.SQEIKA.L.VD.  228
 
HIRRV .S.LR.P.TLGFLDS..IE.K.S....Q...S..V.K.DSGVAA.DTGSEIKG...VD.  228
 
SHRV DTHRITKAVVHGHHPWGLTKACQIQFCNEQWIRTDLGDLIRIEPNDGTSSLTLPKCQDN  293
 
VHSV HD VV  I A  M CTVT CGTE  OVTGQG.AKK.SPK.CVNT  288 
IHNV  ISN.VV..TSY  HR..MIE..GKO  SV.Y.S.AEI.SF...EDK  287 
HIRRV TS.HVV..TSY  HR MIT. GKP  A Y G ATL.AF.A.KDT  287 
SHRV VVQMRGNLDDFSYLNHAIVNMAQRSECLEARSSIVAQQKVSPYLLSKFRPPHPGLGKAH  352
 
VHSV D  AT  L T  T C.D...D.T.SG.I  F  P KAH  347
 
IHNV  TMG  A DDLVKASESRE  AE.ISTNS T Y  INDVY  346
 
HIRRV T.G...S....A..DDLVKSSESRE  AE.I TNS.T Y  INDVY  346
 
SHRV yLONNTIMRGDCIYEGVAEISENRTTYRNIIGEwKK-WSLSRaGK--GYDGMTvGNKIV  408
 
VHSV  .LLDGQ....ECD..A.VSINY.SAQ.KTVENT..P-.NRIDNNT-D..D..IF.DKLI  404
 
IHNV AMHKGS.YH.M.MTVAVD.V.KDR....AHRATSFTK.ERPFGDEWE.FH.LHGN.TTI  405
 
HIRRV AMHDGS.YH.K.MTVAID.V.KDRRT..AHOTSAFVA.GHPFGDENG.FH.LHGNDZPV  405
 
SHRV  IPDLEKYOIYDNGMFIPKLLGEVPHPSIVITYNOTDSIETGIFTDGKLLNMGVNWTLW  467
 
VHSV  ...I ........ S..LVORNLV.I  FVS.TS.I.STNH.H.NLIPSDWSF..S..  463
 
IHNV  VAQ.KTS.MEPMSIKS  LAF.,E..LSGIS.RKLDSFDLQSLH.SF.  464
 
HIRRV  VAQ.KVS.MDKMDIRP  TADIT.RKIDSFDLOSL..SF.  464
 
SHRV PSLSGISLFTVASLILIWYCCC---RVTPQALNYSIPMHTITSRGVEI  512
 
VHSV  MGVVGG.F.L.VLC...---.ASPPLPS.G...QQFSRSOmv  507
 
IHNV  .TI.A.GGIPLVL.LAVAA...WSG.PPTPSAPQ....yHLAN.S  508
 
HIRRV ....A.GGVPILLALVFFLY..MNR.PSMPAAPQE...YHLAS.G  508
 
Fig. 2.3. Novirhabdovirus glycoproteins. Alignment of deduced amino acid sequences 
of the G proteins of SHRV, VHSV ((Benmansour et al., 1997); 1143941), IHNV 
((Koener et al., 1987); 1353204), and HIRRV ( (Bjorklund et al., 1996); 1244406). 
The symbol 0 indicates the amino acid is identical to that of SHRV. The arrow marks 
the verified cleavage location from VHSV. The "*" symbol indicates an amino acid 
which is 0-linked in VHSV-G, and the "+" symbol indicates amino acids which are N-
linked in VHSV. Underlined sequences represent potential N-linked glycosylation 
sites. Letters in bold have been shown to be involved in disulfide bridges. Numbers in 
parenthesis represent proteins' genbank accession numbers. 33 
(Einer-Jensen et al., 1998), and the threonine, which was shown to contain 0-linked 
glycans in VHSV -G (Einer-Jensen et al., 1998) are both conserved among all four 
viruses. None of the amino acids which were shown to contain N-linked glycans in 
VHSV-G were conserved among the four viruses, but SHRV-G and VHSV-G both 
contained the same number of potential N-linked glycosylation sites. 
Phylogenetic Analysis 
A phylogenetic analysis including the predicted amino acid sequences of 16 
aligned G proteins was conducted using the Neighbor-Joining program (Fig. 2.4). 
The reliability of the constructed tree was tested by bootstrapping with 100 replicates 
and analyzing the replicates with both a distance matrix program (protdist) and a 
parsimony program (protpars), both from GCG. The G proteins from four of the six 
genera recognized by the International Conference on Virus Taxonomy (ICTV) as 
well as one unassigned viral G protein (Sigma virus) are represented by this tree. All 
of the groupings among viral genera were in complete agreement with the ICIV. 
In Vitro Translation 
In order to verify that the constructed SHRV-G clone contained an intact open 
reading frame, we translated the clone in vitro and analyzed the size of the protein 
produced on an SDS-PAGE gel (Fig. 2.5). For comparison, the G protein from 
IHNV was also translated. IHNV-G and SHRV-G had predicted molecular weights 
of 57 kD and 58 kD, and apparent molecular weights of 58 kD and 60 kD, 
respectively. 
Transfection and Immunahistochemistry 
The vector pcDNA3-SHRV-G was transfected into mammalian BHK cells to 
verify that the G protein could be produced in mammalian cells from this vector. The 
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Fig, 2.4. Phylogenetic relationship among rhabdoviral G proteins. Phylogenetic tree was 
constructed using the Neighbor-Joining program (GCG). Numbers above and below nodes 
represent the number of times out of 100 the individual nodes were identified when the 
bootstrapped data was analyzed using protdist (top number, GCG) or protpars (bottom 
number, GCG). The G protein aligned amino acid sequences included: vesicular stomatitis 
virus Indiana (VSV-Ind) ((Rose and Gallione, 1981); 138311), vesicular stomatitis virus 
New Jersey (VSV-NJ) ((Gallione and Rose, 1983); 61840), Cocal virus (Bhella et al., 
unpublished; 2865659), Piry virus ((Brun et al., 1995); 506867), Chandipura virus 
((Masters et al., 1989); 138285), SVCV (Rossius, unpublished; 1072745), RPS, bovine 
ephemeral fever virus (BEFV) ((Walker et al., 1992); 418231), adelaide river virus 
(ARV) ((Wang and Walker, 1993); 348028), sigma virus (138305), mokola virus 
(543544), rabies virus ((Anilionis et al., 1981); 333563), SHRV, VHSV ((Benmansour 
et al., 1997); 1143941), IHNV ((Koener et al., 1987); 1353204), and HIRRV ((Bjorklund 
et al., 1996); 1244406). Numbers in parenthesis represent proteins' genbank accession 
numbers. 35 





Fig. 2.5. In Vitro translations of full length G 
proteins. Lane 1 = SHRV-G, Lane 2 = IHNV-G. 
Both G proteins were translated using the TNT 
Coupled Reticulocyte Lysate System (see materials 
and methods). Numbers to the left depict the size 
(in kiladaltons) and location of protein standards. 36 
(Kasornchandra et al., 1992a) (Fig. 2.6). Cells transfected with pcDNA3-SHRV-G 
showed G protein expression throughout the cell, while cells transfected with 
pcDNA3 containing the nucleocapsid protein from SHRV (pcDNA3-SHRV-N, data 
not shown) showed no staining as expected. 
Discussion 
We have determined the nucleotide sequences and predicted amino acid 
sequences of the G genes from the warm water rhabdoviruses RPS and SHRV. Our 
analyses indicate that the virus RPS is essentially the same as the vesiculovirus-like 
virus SVCV, and the two should be classified as the same virus. The G gene from 
SHRV, however, has a unique sequence which is most closely related to 
Novirhabdovirus VHSV. 
Perhaps the most striking discovery of this study is the finding that RPS and 
SVCV are essentially the same virus. This finding is relevant for two primary 
reasons. First, SVCV is a serious pathogen of fish which has definite world wide 
economic importance. Because SVCV was believed to be restricted to Europe and 
Asia, it is essential that it is determined if SVCV has also spread to Hawaii. There 
are only two possible explanations for the findings reported here, either SVCV is 
enzootic in Hawaii, or the virus reported here resulted from a laboratory 
contamination. We believe that the latter possibility is unlikely for the following 
reasons: 1) the virus was isolated from three different shrimp sources (Lu et al., 
1991); 2) infectivity studies verified that the virus indeed infects shrimp (Lu and 
Loh, 1994); 3) PCR analysis on an early passage of RPS verified that the earliest 
viral passages were also SVCV (data not shown); finally, the laboratory which 
isolated the RPS/SVCV had not ever worked with SVCV prior to the isolation of this 
virus. Although we cannot offer an explanation of how RPS/SVCV appeared in 
shrimp at this time, it is none the less critical that efforts be made to re-isolate 
RPS/SVCV from field samples and verify its identity using the probes developed in 
this study. The virus, SVCV, is considered an exotic pathogen and has never been 
isolated from animals in the continental United States. 
The second relevant finding is the fact that SVCV jumped from infecting fish 
to infecting shrimp. Because infectivity studies were performed after RPS was 37 
Fig. 2.6. Mammalian SHRV-G expression. Baby hamster kidney cells transfected 
with A) pcDNA3-SHRV-G and B) pcDNA3-SHRV-N (see materials and methods). 38 
isolated, there is no question that SVCV can indeed infect and cause significant 
mortalities in shrimp (Lu and Loh, 1994). Although this finding is surprising, it is 
none the less characteristic of vesiculoviruses, a genus to which SVCV is closely 
related. Vesicular stomatitis virus (VSV), for example, has been shown to be able to 
replicate continuously in sandflies for ten months and still be able to infect mammals 
(Novella et al., 1995). With this in mind, the finding that SVCV infects shrimp 
actually lends support to the notion that SVCV should be classified as a 
vesiculovirus. 
Once the presence of RPS/SVCV in Hawaii is verified, the next question will 
be to determine whether it is native to the region and simply has not been described 
previously, or it has been recently introduced. A phenomenon similar to the 
RPS/SVCV discovery occurred with the virus VHSV. VHSV was once believed to 
be restricted to Europe, but in the late 80's isolates of VHSV began turning up in 
Salmonids and other fishes in Washington State, USA (reviewed in Meyers and 
Winton, (1995)). While it was initially believed that these viruses were likely either 
laboratory contaminants or new viral introductions, molecular analysis of these 
isolates eventually proved that the North American VHSV strains were not of 
European origin (Oshima et al., 1993). However, in contrast with RPS/SVCV, 
sequences from the North American and European isolates of VHSV differed by up 
to 18% (Benmansour et al., 1997), whereas the difference between RPS-G and 
SVCV-G is less than 1%. If RPS/SVCV is now enzootic in Hawaii, it was most 
likely introduced there recently. 
The phylogenetic tree produced in this study indicates that SHRV groups 
with the genus Novirhabdovirus. This finding is somewhat surprising because 
SHRV is a warmwater rhabdovirus able to replicate at temperatures as high as 35°C. 
Although the phylogenetic analysis suggests SHRV should be classified with the 
Novirhabdoviruses, classification into this genus will depend on whether or not it 
contains a sixth open reading frame which is the defining characteristic of this genus. 
Finally, we have shown here that the SHRV-G has been cloned and can be 
expressed in mammalian tissue culture cells at 37°C under the control of a CMV 
promoter. Because this G protein is from a rhabdovirus that infects at temperatures 
up to 35°C, we believe it will be ideal for the production of pseudotyped retroviruses 
for infecting warmwater fish. 39 
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Abstract 
The nucleotide sequence of the complete genome of warmwater fish virus 
snakehead rhabdovirus (SHRV) has been determined. Sequence analysis revealed 
that SHRV contains six open reading frames (ORFs), which are located along the 
genome in the order 3' to 5' (negative strand): nucleocapsid protein (N), polymerase-
associated phosphoprotein (P), matrix protein (M2), envelope glycoprotein (G), a 
unique ORF presumed to be the non-virion protein (NV), and polymerase protein 
(L). With the exception of the NV protein, all of the encoded proteins were most 
closely related to orthologous proteins from viruses belonging  to the 
Novirhabdovirus genus of the family Rhabdoviridae. No significant similarity to any 
known protein was found for the NV protein. The intergenic regions of SHRV 
contained transcriptional regulation motifs essentially identical to those found in the 
three recognized Novirhabdoviruses. The leader and trailer regions of SHRV's 
genome contained highly complementary ends (16 of 17 nucleotides) and were 
almost identical to the genome ends of the prototype Novirhabdovirus IHNV (11 out 
of 12 nucleotides). A phylogenetic analysis of the aligned amino acid sequences of 
the L proteins from SHRV and other negative-stranded RNA viruses placed SHRV 
in the genus Novirhabdovirus where it grouped more closely with species, viral 
hemorrhagic septicemia virus (VHSV). 
Introduction 
Snakehead rhabdovirus (SHRV) is an aquatic warmwater rhabdovirus 
isolated from a diseased snakehead fish (Ophicephalus struatus) during  an epizootic 
outbreak in Thailand (Wattanavijarn et al., 1986). The disease caused characteristic 
necrotic ulcerations in both wild and pond-cultured fish throughout southeast Asia 
(Kasomchandra et al., 1991). Although several fish species were affected by the 
disease, it most often appeared in the cultured snakehead (Ophicephalus struatus), the 
walking catfish (Clarias bratachus), and the sand goby (Oxyeleotis marmoratus). 
SHRV was one of several pathogens (viral, bacterial, protozoan, and fungal) 
associated with this ulcerative disease (Frerichs et al., 1986, Hedrick et al., 1986, 
Kasornchandra et al., 1992a, Wattanavijarn et al., 1986). and efforts to identify  a 44 
single etiologic agent have produced equivocal results (Hedrick et al., 1986). Initial 
characterization of SHRV using electron microscopy, cross-neutralization tests, and 
protein electrophoresis profiles indicated that it was a unique rhabdovirus with 
characteristic bacilliform morphology and a protein expression pattern most similar to 
members of the genus Novirhabdovirus. This genus includes VHSV, IHNV, and 
hirame rhabdovirus (HIRRV) (Kasornchandra et al., 1992b). 
Our laboratory recently began the molecular characterization of SHRV by 
cloning and sequencing its glycoprotein (G) gene. The amino acid sequence of this 
protein was found to be most closely related to the G protein of VHSV (49% 
identical), and a phylogenetic analysis using the G protein indicated that SHRV 
should be grouped with VHSV in the  genus Novirhabdovirus (Chapter 2). The 
finding that SHRV-G was so closely related to the Novirhabdoviruses  was 
surprising because SHRV is  a warmwater rhabdovirus able to replicate at 
temperatures as high as 35°C, whereas the three known Novirhabdoviruses 
optimally replicate below 20°C. 
There were two reasons for sequencing the complete genome of SHRV. 
First, although phylogenetic analysis of the SHRV G protein sequence placed the 
virus in the genus Novirhabdovirus, the ability of this virus to replicate at warm 
temperatures suggested that SHRV might be a recombinant virus with  a 
Novirhabdovirus-like G gene within a Vesciulovirus genome like spring viremia of 
carp virus (SVCV). Also, the hallmark feature of all Novirhabdoviruses is a small 
ORF of unknown function found between the G and L genes, the NV gene. By 
sequencing SHRV's genome, we could determine if SHRV contained this extra 
gene. 
The second reason for the sequencing effort was a need to develop a system 
for analyzing the functions of the regulatory elements and genes of this rhabdovirus 
of fish. In recent years, researchers have developed the technology to recover 
recombinant negative-stranded RNA viruses from cDNA clones; this technological 
breakthrough allowed reverse genetics experiments to be performed on negative-
stranded RNA viruses (for review see Conzelmann, 1996). Reverse genetic analysis 
of the genes and regulatory elements have been reported for several types of 
negative-stranded viruses. However, the reports have been confined to mammalian 
viruses which can replicate at 37°C because the procedures rely on expression 
vectors and protocols designed for optimal performance at the mammalian body 45 
temperatures. The procedure involves co-transfection of virus susceptible cells 
already expressing T7 polymerase with plasmid DNA which contains a cDNA copy 
of the entire genome of the RNA virus under the control of  a T7 polymerase 
promoter and separate expression plasmids which encode the viral proteins necessary 
for viral transcription and replication. The coexpressed proteins begin transcription 
and replication of the newly synthesized genomic RNA, and in a small fraction of the 
cells, a productive infection is induced. 
For a typical Novirhabdovirus, which cannot replicate above 20°C, reverse 
genetic analysis of the virus is exceedingly difficult for several  reasons.  First, T7 
RNA polymerase has optimal activity at 37°C, 17°C higher than the maximum 
replication temperature for typical Novirhabdoviruses. Second, the high level of T7 
expression required to induce a productive infection is obtained by pre-infecting cells 
with a recombinant vaccinia virus which overexpresses T7 polymerase (Fuerst et al. , 
1986). While vaccinia virus can infect nonmammalian cells, productive infection can 
only occur at temperatures over 300C (Dennis Hruby and Christine Franke, personal 
communication). Because SHRV replicates at temperatures as high as 35°C 
(Kasomchandra et al., 1992a), we believe it will be a suitable virus for performing 
reverse genetics experiments. The first step towards performing these experiments is 
obtaining the full-length sequence of the SHRV genome. 
Precise knowledge of SHRV's genome is required for taxonomic assignment 
of the virus and for potential genetic manipulation of the genome. Here we report the 
cloning and sequencing of the complete genome of SHRV. Analysis of the ORFs 
suggests that SHRV should be classified as a Novirhabdovirus.  Knowledge of the 
complete genome sequence makes SHRV an ideal candidate for performing the first 
reverse genetics experiments on a nonmammalian negative-stranded RNA virus. 
Materials and Methods 
Cells and Viruses. 
Epithelioma papulosum cyprini (EPC) cells were used for viral propagation 
(Fijan et al., 1983). The cells were grown at room temperature in minimal essential 
medium (MEM) supplemented with 10% fetal calf serum and 2mM L-glutamine. 46 
SHRV was obtained from Dr. John Fryer, Oregon State University. EPC cells were 
infected with SHRV at a multiplicity of infection of 0.5 and incubated at room 
temperature until 70% of the cells exhibited cytopathic effect (24 h). The infected 
cells were collected and used in subsequent RNA purification. 
RNA Purification 
Total cellular RNA was extracted from infected EPC cells with RNAzoI (Tel-
Test, Inc., Friendswood, TX) according to the manufacturer's instructions. 
Messenger RNA was separated from the total RNA using an Oligotex mRNA kit 
(Qiagen, Palo Alto, CA). 
cDNA Cloning (P and NV) 
The G gene was cloned using a modified rapid amplification of cDNA ends 
(RACE) technique, as previously described (Chapter 2). The phosphoprotein 
(referred to here as P, but also known as M1 and NS) and non-virion (NV) genes 
were amplified using the SMART PCR cDNA Synthesis Kit (Clontech), a technique 
which amplifies full-length cDNAs from mRNA using PCR. The SMART 
procedure was performed using mRNA collected from SHRV infected cells, and the 
resulting PCR products were separated by electrophoresis on a 1% agarose gel. 
PCR products equivalent in size to the predicted sizes of the NV and P genes were 
subcloned into the TA cloning vector pCR2.l according to the manufacturer's 
instructions (InVitrogen, San Diego, CA). 
cDNA Cloning (M2) 
The gene encoding the matrix protein (referred to here as M2, but also known 
as M) as well as the P/M2, M2JG, and G/NV intergenic regions were obtained by 
PCR amplification from genomic cDNA using SHRV specific primers. To produce 
the genomic cDNA, 1 lig of total RNA was mixed with 50 pmoles of random 47 
hexamers, 20 nmoles dNTP, 4 ittl, 5X AMV-RT buffer, 10 units RNasin (Promega, 
Madison, WI) and 10 units AMV-RT (Reverse Transcriptase, Promega) in a total 
volume of 20111, and incubated for 1 h at 42°C. Following reverse transcription, the 
cDNA was mixed with 900 [IL H2O and 1µL from the cDNA reaction mixture was 
used as template for each of the subsequent PCR amplifications. Two PCR reactions 
were performed using this cDNA, the first reaction amplified the region between the 
3' end of the P gene (primer ME 526 5'-AAGGCTGAACTCACAAAGTGAC-3') 
and the 5' end of the G gene (primer ME 527 51-GTTTCATGTTTGGGAGCGTC­
3'). This amplification generated a PCR fragment containing the M2 gene as well as 
the P/M2, and M2/G intergenic regions. The second PCR amplified the region 
between  the  3'  end  of  the  G  gene  (primer ME 355  5'­
TCCAGATGAGAGGGAACCI'GGA-3') and the 5' end of the NV gene (primer ME 
512 5'-GATGGGACATCTAGTTTCTCTACCAGG-3'), generating a PCR fragment 
encoding the G/NV intergenic region. PCR reactions contained: IX PCR buffer, 1.5 
mM MgC12, 200 µM dNTP, 20 pmoles of each primer 1µL cDNA, and 2 units Taq 
polymerase (Promega).  Amplifications were performed in an Amplitron II 
programmable heating block (Barnstead/Thermolyne, Dubuque, IA) using the 
following parameters: 35 cycles of 30 sec at 94°C, 30 sec at 55°C, and 2 min at 
72°C. PCR products of the correct size were subcloned into TA cloning vectors 
according to the manufacturer's instructions (InVitrogen). 
cDNA Cloning (N and L) 
The genes encoding the nucleoprotein (N) and polymerase (L) were cloned 
using the Universal Genome Walker Kit (Qiagen), a PCR based procedure for 
cloning unknown DNA regions adjacent to known DNA regions. The procedure 
was performed according to the manufacturer's instructions with one exception: 
instead of using genomic DNA as the starting template (which rhabdoviruses do not 
have), an equivalent amount of undiluted SHRV genomic cDNA prepared  as 
described above was used. 48 
cDNA Cloning (Genome ends) 
The genomic ends of SHRV's genome were obtained by ligating the two 
ends of SHRV's genome together followed by RT-PCR through the junction. This 
was performed by mixing 2 Rg of total RNA, 1  pl. T4 RNA ligase (Life 
Technologies, Gaithersburg, MD), and 1 p,L 10X ligase buffer in a total volume of 
10 tiL and incubation for 1 h at 37°C. Next, 1 RI, of the ligation reaction was mixed 
with 50 pmoles of a reverse primer specific to SHRV-P (ME 540 5'­
TCCTCCMAAGGTTCTCTTGTGTCTTGG-3'), 20 nmoles dNTP, 4 pd., 5X 
AMV-RT buffer, 10 units RNasin (Promega), and 10 units AMV -RT (Reverse 
Transcriptase, Promega) in a total volume of 20 pl. and incubated for 1 h at 42°C. 
Following the reverse transcription, the reaction was diluted to a final volume of 100 
with H2O and 1µL was used in the subsequent PCR reaction. The PCR was 
performed as described above except the reverse primer was SHRV-N specific (ME 
570 5-GACCACCCACTGCAGCCAAGGCCTTGATG-3') and the forward primer 
was SHRV-L specific (ME 582 5'-GGGGGATCGCTGATCAGGACAAACGAGA­
3 '). 
Sequencing 
All DNA sequence analyses were performed by the Oregon State University 
Center for Gene Research and Biotechnology Central Services Facility on a 373 
DNA sequencer (Perkin Elmer Applied Biosystems). To avoid interpreting 
nucleotide errors introduced by the polymerase, all regions of the SHRV genome 
were sequenced at least three times. 
Sequence Analysis 
The amino acid sequence of the SHRV genes were deduced using the 
sequence editor of GCG (Wisconsin Package Version 9.1, Genetics Computer 
Group, Madison, WI). The predicted amino acid sequences were compared were 49 
with known sequences by performing individual gapped BLASTP (version 2.0)
 
searches (Altschul et al., 1997).
 
Results 
Cloning of the SHRV Genome 
A series of PCR-based cloning strategies were used in the cloning of the 
entire SHRV genome. The cloning of the G gene was described previously (Chapter 
2). The NV and P genes were cloned by PCR amplification of total cDNA from 
SHRV infected cells using the SMART PCR cDNA Synthesis Kit (Clontech) and 
cloning the PCR products equivalent in size to rhabdovirus mRNAs into pCR2.1. 
Because the rhabdoviruses are non-segmented, we were able to obtain the genomic 
region between the P and NV genes by PCR amplification from genomic sequence 
using P and NV specific primers. 
The genes at the genome ends (N and L) were cloned by "walking" using the 
Universal Genome Walker Kit (Qiagen). Finally, the genomic termini were cloned 
by ligating the genomic ends together and PCR amplification through the junction. 
Multiple PCR products, several of which had partial deletions at the 5' or 3' end, 
were sequenced. We believe the sequences reported here are indeed the genomic 
ends because: a) both ends were confirmed by multiple PCR analyses, b) the 5' and 
3' ends are complementary, which is typical of all rhabdoviruses,  and c) the 
sequences are nearly identical to those reported from IHNV, a closely related 
rhabdovirus. 
Genomic Proteins 
Sequence analysis of all three reading frames of the positive-sense genome 
revealed six potential ORFs greater than 100 amino acids in length (Fig. 3.1A). 
These ORFs match the six Novirhabdovirus orthologous protein both in size and 
orientation. A similarity profile obtained by comparing the aligned SHRV and IHNV 
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Fig. 3.1. (A) Schematic of all open reading frames in the SHRV genome. Short 
vertical lines represent potential start codons and long vertical lines represent 
potential stop codons. All open reading frames greater than 100 amino acids in 
length are shaded gray. (B) Plotsimilarity profile (GCG, window 200) between 
SHRV and IHNV genomes. Genome nucleotide sequences were aligned using 
the program Gap (GCG). 51 
conserved gene is the L gene while the least conserved is the NV gene (Fig. 3.1B 
and Table 3.1). The complete genome of 11550 nucleotides with the 6 predicted 
ORFs is shown (Fig. 3.2). 
The first ORF, extending from nt 174-1373 encodes a 399 amino acid (43 
kDa) protein presumed to encode the N protein. The encoded protein is 47% and 
44% identical to VHSV and IHNV, respectively, with the highest region of 
homology occurring between amino acids 200 and 300, where the identity is 
approximately 70% between all 3 viruses. This highly conserved region corresponds 
to the region proposed to be the RNA binding domain of VHSV-N (Said et al. , 
1998). Like VHSV-N and IHNV-N, SHRV-N has a low pi (5.02) and has several 
acidic amino acids in its C-terminal end. 
The second and third ORFs, extending from nt 1588-2250 and nt 2365-2934, 
encode 220 amino acid (24 kDa) and 189 amino acid (21 kDa) proteins, respectively. 
These genes are presumed to encode the P and M2 proteins. The encoded proteins 
are 42% and 48% identical to the VHSV P and M2 proteins, respectively. These 
SHRV proteins are the most basic proteins of the virus with pis of 9.02 and 9.58, 
respectively. 
The fourth ORF, encoding the G protein, has been described previously 
(Chapter 2).  It has two potential start codons representing either a 507 or a 512 
amino acid (58 kDa) protein. This protein is most similar to VHSV (49% identical) 
but has significant homology with such divergent rhabdoviral G proteins as 
mammalian rhabdoviruses vesicular stomatitis virus (VSV) and rabies as well as 
plant rhabdovirus sonchus yellow net virus (SYNV). 
The fifth ORF, extending from nt 4897-5265, encodes the smallest and most 
unique of the SHRV proteins. The encoded protein is 122 amino acids in length (14 
kDa), which is approximately the same size as the NV protein found in all 
Novirhabdoviruses to date. However, the encoded protein has no significant amino 
acid identity with other NV proteins or any other proteins in the available protein 
databases. Furthermore, we could detect no similarity with other NV genes in 
acidic/basic amino acid distribution, cysteine distribution, or hydropathy. The pi of 
the putative SHRV NV protein is distinctly acidic (5.54), while all other known NV 
proteins are closer to neutral. 52 
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Table 3.1. Predicted SHRV proteins. Amino acid sequences from SHRV were compared 
with available sequences from viral haemorrhagic septicaemia virus (VHSV), infectious 
haematopoeitic necrosis virus (IHNV), Rabies virus, and Vesicular stomatitus virus, 
Indiana isolate (VSV). Percentages of identical amino acids is shown. Calculated 
lengths, molecular weights, and pis are shown. 
NS, no similarity, comparisons were assigned this value only if a) no similarity was 
found using the gapped BLAST analysis, and b) pairwise alignments resulted in less 
than 20% identity. 
The symbol "*" indicates that the homology was determined only over a highly 
conserved 1000 amino acid stretch. 53 
Fig. 3.2. SHRV genome. Uppercase letters represent open reading frames. 
Underlined letters represent conserved intergenic regions. 54 
1 gtatcaaaaa agatgatgat acttggaaga agagatgaag gaaaagaaaa agatggoacg
 
61 taagttgcaa agagtttcag tttaccaaaa cagaaagccc tagaaacaag cgtgagatat
 
121 cagaatctga cacagaggag agatatcaag aatcaaaccg agacaatcac aagATGGCTT
 
181 TWAGAANGA GTTCTITGGA CTGAGAGATG TGAAAGTOGA TruATCCGCT MAGNA:ART
 
241 TGGACTTTGA CCCATCCGAG GTMAATTGA CCGTrTATCG GACCGGGGCT GATACTGATG
 
301 GAAACACCAT CATCAAGGCC TTGGCTGCAG TGOOTOGCCC AAAGACCAAT GAGGCCCTAT
 
361 CANNAITTTT Golammrc ACGTTAGGCA CAGATCAAGA TGAATATGAG ACCAGGATTA
 
421 AGATCTTGAAAGAGATTGGA TTCAGTGTAA AGGAGGTTCC CATGGCGAAA GATGCAAGTT
 
481 CGGGGATTGA GGCGCCGCM GAGAATGTTG CAGCATTAGT CAAGCCCGAG ACTGTCTATC
 
541 AGGTCATCAG GGGAGTATTG TACACATGCG CGTTATTTGT TAAGTATAAT GTGGAAAAGA
 
601 TGCAGAAGTA CATCAAGAAT AAACTACCTG CACTGGCTAC CAGTTACGGA GTGCCCGAGC
 
661 TAGAAGAGTT TCCGACCGAG TOCTCCGCCC TCAAGAAGTT GOMM= ATTCGACCCG
 
721 GGCAGAGGAT TACCAATOCC CTCTATGCTT TCCTCCTGGT AGAAATGGCG AGGCCAGAGA
 
781 CCCAGCAAGG AGCCAGGGCG CTCGCAGCTA TGAGAATCAA CGGGACAGGG ATGACTATGG
 
841 MX:Inn:ITT CACTCAGGCG GCAAAGAATC TGGGAGCCAC ACCTTCTGAC CTCCTGGAGG
 
901 ATCTTTGCAT GAGATCCCTT GTGGACTCTG CAAGGAGGAT CGTACCACTG ATGGTCCAGG
 
961 TATCTCAGGC TGAAACCATC CAGGCCCGCT ATGCTGTAAT GATGAGCAGG ATOTTGAATG
 
1021 AGAATTACTT CAAGGCCTAT GGGCTCAACG ACAACTCAOG AATTTCCGCA ATCCTGGTTG
 
1081 CTGTGAATGG TCACTTCAGT GAGGACACCA TTGAGGCACT GGAGGGAATC AAGGTCTCCG
 
1141 CAGAGTMGC TGACCTCGCC CGCAGGATTG CAATCGCTCT AATTGAAAAG TATGACAATG
 
1201 CAAGINIMG AGGAGAGGGA GCATCCGAGA TCATCAAGAG TGCTGTCCGT GGGTCATCCG
 
1261 GGGCTTTCAA AGGATCCCGA GGGAAACCAC AGGGAAGAAG ACAAGAGGCC TCGGGGGAGG
 
1321 GGGATCTTGA CTCAGAAGAT GATGACGATC AGGACTACAG CAAGTATGCC TAAaacagaa
 
1381 cttcccccct aacgagtgac aacagaaggt caaatcatga attgcgatga ttgtgtctgg
 
1441 ctaaccagcc aaaacatggt gaactggagg gggaotccag atcacagcca cccctcggag
 
1501 agtagataga aaaaaacg. acgagagtgc ttaaatattt gaaacccaaa caacccgccg
 
1561 ccaagacaca agagaacctt caggaggATG GCAGAATCGA TCGAGATGGG AGAAGAALii
 
1621 GTATCCAGTC CCTCCNIMOT GCTGGCCCTG AAAGGCAAGC TAGAGANDOC GTCCCCTGAC
 
1681 GATGCCACGA TTCTGGGAAT CCIGGGCAAA AAAACGCCAA CIOXIAAJNAT GGAGAAGGGG
 
1741 AAAGGGAAAG GTGACCCAAT TGAAGCATTC CTACTGGAGT TCGTAGNMA GAGGAGGCAA
 
1801 GTTGAGGCAA ACAAAAGACT GAGACAGTAC ATTAGACAAC TTAAGATGAG CCATCAGGAA
 
1861 GAACTGACCG CTCATCTCGA GAGGGCCTCC GCAGAAAACA GAGCAAATCT CAAGTCCATG
 
1921 ATGGAATCTC AGGCTGAATC CAACAAGACC ACAAAAACCA TCCTAGCTAC TCTGATCACT
 
1981 CTACGAGACC ACGTCATAGA AGAAGGGTCC AAGAAACCCA GAGGCCTAGA TAAAGATCAA
 
2041 ATCAAATTAG AGAGAGCTCT AGGTTTTGAG AGGGGGTAGA GCTCAGCCAT CGCCATCGTG
 
2101 AATCAGCTCA AGGTGACGGA GCCCTCTCAA GICMCAARC CATCMNING GGCAGCAGCA
 
2161 CTGTCAGCCA TGGAGAAAGG AGAGTTTGAG AGCTCCGGGG AGGTGTTCAA GGCCGTAGTT
 
2221 AAGAGGGCGA AGGCTGAACT CACAAAGTGA ccacccacac coaactcagg ctcaaagtca
 
2281 gcatagacag aaaaaaatgg cacgagagtg ctaaaatcct gacagaagag cggaatcgag
 
2341 aaaaacggat caaaagagat caaaATGCCC TTCATTCGTC GTCCTAAACG AGCAATTCTG
 
2401 ATACCCCCCC TACATCTCAC ACTGAAGGAT GATGACAAAG TGPIMANAGT TGAGACCGTG
 
2461 GGGACCCTGA TCATATCAGG GATGACTCCC AGTAACCTCA CAGAGAAACT GGGTCTTGCC
 
2521 ATGAAACTTG CAAGMAANT TCTAGGGGGC GACTCMATC CCGCATMAK TCCTCTAGTT
 
2581 GAAATATTC4 GTGGGGCAAT GGAATTTGGG GCCTCAGTGG AGAAACTGGA CTTCATGACC
 
2641 CGGGAGANCA AAGTCATAAC CACCTACAAK GTCGCCCGTG GTAAGGCTGT TGCCCTATCC
 
2701 AACTTTCCCA TGGAGAAACG AGTTGGAGAG AAAAGCTACA CCACCCAGAT CAGGAATGGG
 
2761 AGTATCACCT ATACAGGGTC CTTCCTATTC TCTGCGGAGC ATGTOGGACT GAAGGATAAC
 
2821 CGGAGTTTGT TTGCAGCGGG GGAGGGACTT AGAGAGAGCC CCGACATGGC ACAGGCCAGG
 
2881 GAAGOCTTTG CAC :MOOT ACCAAAGGGA AAGAACGAGT CCTCAAGAAA GTGAacctga
 
2941 gaaggagaaa caggggaatg gcaatcggtg tcaaaaatct ggggaaatga gcgatcaggc
 
3001 tatcgggcac tggaagagcc cggacaccca tcccagaccc ctggtctgca ggaccacacc
 
3061 gatacaccca gccgtctgaa gtccccatca atatgacccg catggcgaac  ccaagaaaga
 
3121 caactctcca tctcctcaca agaaagacag aaaaaaatag cacgagagtg cttaaatata
 
3181 acagaacaag gtcttagctg caATGACGCT CCCAAACATG AAACCAAAGA GGATTGTCCT
 
3241 GTTTCTGGTG TTCTTGAATG CCTGGGTCTC CAATGCMAG GTGACTCACAAGCCGAGACC
 
3301 AGATAGCATT GTCGAGTACT CGGAAGAATG GGAAAATCCC ATATACACAA CCCCCAGCCA
 
3361 CTGCTTTGAA GACACATTCG CCCCCGTTAA ACCGGAGAAA CTGCGTTGTC CCCACATATT
 
3421 TGATGACCAG AATCTAGGCC TCACAGCATC AAAGGCGAAA ATCCTGCACA TGGACCTCAX
 
3481 ACCAGAAGAT ACCCATTTTG AGGCCAAGGG AAGACTCCTC CACAAGGMA CATATCAAGT
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3541 Tanmpcmcc ACAGGGTTCT TCGGAGGAAG GACCGTGACT  CGAAAAGTCC TGGAAACTCC
 
3601 CATWAXAINC AATGAGGCCC AAGOCTACAA GGCAGTGGAT CGAGAGTTTC CTTATTTCCC
 
3661 TGAGCCGCTC TGTTTTTGGT TGCGAGACAA TGTCGCAGCC GAGCGAGTTT TTCATTTTTC
 
3721 CACCCCAAAA ACAGTGACGG TCGATCTCTA CAGTAGAAAG TACATCAGCC CAGACTTCGT
 
3781 AGGGGGACAG TOTGCCAAGT CGCCCTGCCC CACTCATTGG CCAAACGTTT ATTGGGTCGG
 
3841 GGAAACTCAA TCXXXAMAAAT GTCCCTOICAT TGATAChGAA GGGGGGCACA TTTTCACCAA
 
3901 GAAGGACACC CATCGGATAA CCAAAGCAGT TGTGCATGGA CACCATCCCT GGGGATTAAC
 
3961 CAAGGCCTOT CAAATOCAAT TTTOCAATGA ACAGINAINTC AOGACNINCC TAGGGGATCT
 
4021 TATAAGGATT GAACCTAATG ATGGGACCAG TTCACTTACT CTCCCAAAAT GTCAGGACAA
 
4081 TGTCGTTCAG ATGAGAGGGA ACCTGGATGA TTTTTCCTAT CTGAACCACG CAATTGTTAA
 
4141 CATGGCGCAG AGATCTGAGT GTCTAGAAGC TCACAGTTCT ATCGTCGCTC AGCAAAAGGT
 
4201 CTCCCCTTAC mamma& AATTCAGACC TCCACACCCT
  GGACTOGGGA AGGCACACTA
 
4261 CTTACAAAAC AACACCATCA TGAGAGGGGA TTGCATCTAT GAGGGAGTGG CCGAAATCTC
 
4321 CGAAAACAGG ACAACATACA GAAACTTAAA GGGCGAATGG AAGAAGTOGT CTCTGAGTAG
 
4381 GGGGGGGGAA GGATACGACG GCATGACAGT CGGAACAAAG ATTGTCATCC CAGATCTAGA
 
4441 GAAGTATCAA AGTATTTATG ACAACGGTAT GTTCATCCCT  AAGCTTCTOG GAGAGGTCCC
 
4501 TCACCCCAGC ATAGTGATAA CCTACAATCA GACCGACTCA ATAGAGACAG GCATCTTCAC
 
4561 AGATGOTAAG CTOCTCAACA TGGGTGTAAA TTGGACTCTC TGGCCATCTC TCTCGGGTAT
 
4621 CTCACTCTTC ACTGTGGCCT CTTTGATCCT CATCTGGTAC TOKINAATACC GAGTGACTCC
 
4681 GCAAGCCCTG AACTATTCAA TCCCGATGCA CACCATCACC AOCAOGGGAG TAGAGATCTG
 
4741 Atgoggtcao tcaggccoca tcacagtgtc actccaagaa gtcgggaccc ccaagagact

4801 caagcccaat cacgagpmaggammmacsggagtatagt gcacaatcaa agaaccgtcc
 
4861 aagcacaccc aggaacagaa gaacgaaact gcoaacATGC CCGGCAACAA CCACAATGAC
 
4921 CGCCCCGTCG CCCTAATAAT GTCCCGCCTC TCITUAMACC CTAGAGACAG CATCCATCAC
 
4981 ACCGTTGACA CCCGAGGCAT GACCCCCGGA AAAATCATCC ATCAGGTGAT CCCTCCTCAT
 
5041 CCGACCCAAA TGAGGCACAC AAATCGCCCC TCGCCCCCTG TCATCCTCAA CTTGCAGATC
 
5101 CTCTCAGAAG GGGGACACGT CTGTGCAAGG GATGTGGACA CCGCAGACCC AGTCCCAAGA
 
5161 GCAGGACCCG AGAGAACCAT CCAGTGGGGC ACGGACCGGG ACGCCACAGA AGAACTAGCA
 
5221 TCTCCTGCCC CAGAGGAGAT ATATGAAGAC AACGACTCCT GGTAGagaaa ctagatgtec

5281 catattattt ataUguidAmtaasmagacgtaatgtgc ttaacgaatc gtagcagaag
 
5341 aaaaggagaa gaattcattc tcaagcagga acaccacact tcaaacctcc aaacacccct
 
5401 cctcaggacc aaagacctca aagactaggc cctccatcaa cccacaacgc cCcagtccca
 
5461 ttcaatcccc cgactgaaac ggacaggagA TGGAATTTTT ranarGoAc CTCGAGGTTT
 
5521 CACAAGAGCG CCTTCCAGCA GAATGCTCAC TGAATGCTCC wilammaT TCATTGTCTC
 
5581 TCCAACTATT TGGGAGAATC GAGCCAAAGA CGGAGAACAT CAGGAGACAA TCCAGAAGGA
 
5641 TTACCAAAGT ACTCAGGGAA AGACACAACG GATACAGGCT CCAGGATTTA ATCATAGACT
 
5701 CAACTAGGAC TCAGOCCAAC CTAATTCCCC ACCTGGTTAG CTCTGCCTCT GGTGACCTCA
 
5761 ACACTCCGAT CTTGGAGCAC TGGGAAATGT TGAGTAAGTA TTACCAGTCA TTAGGGTACT
 
5821 CACTTCCTAG CCTCGACAAG TTCGACTTCA AAGAGTCAGC TGGATACTGG AACGCCGCAT
 
5881 GTTCTTTTAG AGACATGCTC TTAAAAAGCC AGAAAGTCGA GAMAAAPOTC AATAAACAM
 
5941 AAACATATGT CATTTATGAT ATCACCTTTG AATTTGTGGA GOGAGBATTG TTCATACACG
 
6001 GAGGTGAAGA CGGGTTTANT GACGGTTTCC TGGCAGGAGG AGCAATTGCA  GCCATGACCT
 
6061 ATACTGAGCT uxTAGCTCTA TTTAAAATCT TGAATCAGCG AGCCCAAGCT CTCTTGATGT
 
6121 GTAACATAAG CAAAGGACTT GAACCAGACA TGGTOICCCAG TCCCTUAIACT ATTCACTCGA
 
6181 TCTATGCAGA GGCTGACCAC ATGCTAAQAA TGGCGGGACA  AGGTGCCATC GATCTACTAA
 
6241 AGCTGTGGGAACCTCTGGTC CTTACTCAAT TAGGTGACGT ACTGGGCGAC AGATTTGGGC
 
6301 TGGAAGACGA CTTCAAATTA ACTATCAGAA CAGAGGCGGC GCTGCTCGCC GATCAATTGA
 
6361 ATCTCAAGAG GAGCTTCGCA AGGATGACTG AGCTAATCAA GTCAGAGACA CGCAAGANGC
 
6421 CTCTTTTCCA GCTATTCGGA TTGTTCAAGC ACTTTGCTTA CCCCCGGGTT  TACTCAAGGG
 
6481 ATACTATCAA TACTATCTTG GGGGTCAGTG ACAAACMG CGCAAATGAC CCAGAGGAGT
 
6541 ACCTACATGA CCAATGTGAG ATTCGAAAGG AATTCTACAC GAGATATGTC AAGGCATATC
 
6601 ACCGTGCGCC CCAACTGGAC CTGGGAGGAT TAAGTCCAGG Gmannkom AGAAGAGCAC
 
6661 TGGAGGCAGG GAAAATGCCG AATGAAANAA GTCCTTTGTA CACAAATTTG GAGTGGTTTT
 
6721 TTGTGAAATT CAAGAAGAGC ATCGAGTGGC CTCTCAGTGA CACGCTCTACT ACATTCCTCT
 
6781 CTGACAAGGC AATCACCCAA AATAGGAGCA CATGGCTOGA CAACGAGACG TCGTCCAGAG
 
6841 ATAATTCTGA AAAACGArTG CTCCTCAAGT TCATCAAAGA AAACGAGGAC AGTGTCGCAA
 
6901 GGGTCGTTGC CCAACAMAAA GAAATTTACG ACAATGAAGA  CGACAGAATA ATTGCTCTCA
 
6961 AAGTCAAAGAAATGGAGCTG AAACTCAAAG GTCGGGGGTT TAIGACTAATG ACGTTCAAGC
 
7021 CCCGTCTGCT CCAAGTTTTA AGAGAGA$3CA TTGCGAAGAAAACTAGCAAA CTGTTCCCAG
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7081 AAATCACCAT GACTGCATCT GATCTAGATC TGAAGAAAAG GAAGTTCCTC GTATCCCGAA
 
7141 AGAGTGATGA CAGGAGGGGG TATGTGCACA TGAGTAAAAG annnulpac AATAAGTTCT
 
7201 GCACCAGCCA GCGTCAGTTC AACTCACAGG CGGTAITTTCA GTGCCTGGAC GAAKANUAACG
 
7261 GAACTGGAGC mannmpra CGRAANAANCG AGATATTAGA GAGOVAVAGG ATCGTGGACG
 
7321 GTTCAGCTAG TGATCCTCCC AACCTAAAAA AGTTTAAGGA TAGATACCAG AAACTCAAGG
 
7381 ACTTGGGGAT TGACGCACCA CACACCTGGG GAGATGGAGT GUTCANAAAGG CTAATGGGGG
 
7441 GGATCGAAGG GC/GTO/CM TATGTCAGGA CAATTTGTCT TTTGTTGAGA GTCGAACGAG
 
7501 TGCTCTCCAA GACAAGTCTG ACCCACTTCG TGATGGCACA GGGAGACAAT GTTATCATAA
 
7561 ACTTGATCAT CCCAATTGAG ATCGAGAGGG ATGGGTCGAT ATCACCATCA GAACATCGGA
 
7621 GGCTCAAGTC CTTGAGTACC TCGATTGACA CCCAGCTTGC AATGGAGCTT GAGAAAAGTG
 
7681 GATTGACCTT GAAGATAGAA GAGACACTCA GCAGTGAGCA CATCTCCATT TACGGAAAAG
 
7741 ACCTCCATTG TCCTCATCAC CTAACCCTGT CCTTGAAAAA GGCAGGATCC GCCTCCATTA
 
7801 TCTCTAGTGA ACAGTATCAA GATGTGCCGA CCTTTCTAGC AGGCCTTAGC ACCAGCATAG
 
7861 AGACTATCTC TGAGTGTGTC AACGACAAAG TCAGTGCCCA CTTATTTGGG GTGATCCTCG
 
7921 CACATGCCGG GTGGAAGAGC CTCTGTGTGA GTCAGACTTG GAAGGGATGG GAATATCCCT
 
7981 ATCAGAAGGA CGAGACGATT AACAGGGTTA GAAGTCAAGG AATCAAACTC ACAGAGGGAG
 
8041 AGCAAGTAAC TGTCGAAAAA AGACTAGAGC GAAATCCAGA CAAACGATGC CTTGAATGGA
 
8101 Torcnnwarx cAGTTTccTs GGATCGGCCC TCGGAATGCT =Imam ACTCCCGTAG
 
8161 ATCTAGAGAA ACGAGGTGTT GGGGACTACA TCACCCATAG ACTTGCACTC ACAAAAAAGG
 
8221 CGCTGAGCTC aimarrerc CCTCGTAGAA TCGAGAAATT GATCAAAARAC ATGOTCAATT
 
8281 TACCTCACTC AMAAIkAACT GACTTGGCGA AGTTGTTCGA TTCACCCTTT TCACTGAACT
 
8341 TGGCAACCGA GGAAGATGCAACGICTGTGA TAAAAAGACT GGCCCGATCC ACGCTCCGGG
 
8401 ACCTGGACAT CAAAAACGAG CGACTTCGTG CCCACATCGA TATAATGGAC AGAGGTCTTC
 
8461 AAGACCTAGA TCGAGAGTTA GGTGACTCTG AAACCATCAA TCCCAGCGTG GCACACCTCA
 
8521 TTCGGGACAT CACAGATGAG AAGGAATCGG AGATGTTTGT CACCAAATTT GCCACTGCAA
 
8581 GGACAATGAG GACAGTGGCC TIGGAGAATC CCCAAGATGT moms= AGCTTACTCA
 
8641 ACAAGAAGAG TCGAGCAAAG GAGACGTACA CAATCTGGAG ATCAAAAAGA GCCCCAGCAG
 
8701 AAGACTGGGA ATGCTCGACT CAACGAGCAA AAATAGAACG AGACTCTTCA TGGGGAAAAA
 
8761 ATGTGATCGG TGTGACCTCC CCCTCACCTG TTGAGGCCAT GAGCTATCGA CTAGTTGACC
 
8821 CGAGCACCTG GGAGGAAGAG AAGAAAGACC AGGACTTCAC AATCAATTAC TATCTCTCTA
 
8881 AACCCAGTCT TATTTCCCAC CAGGCAAGGC TTGAACGAGG ACC/TTAGTG CCTTATTATG
 
8941 GGACTCAGAC GCAGCCACTC ATAGCGAAGG CATACAACGA ACTAAAAGGAAATCCAAAAA
 
9001 CCAATAAGGC ACTCATGCTC CTCAGCCTCA GAGAAACTAT TGTAAAATCA GGATCCAATC
 
9061 TTGATAAGTT GATAATGCGA CTCTGTGAGA GGGCGCTAGA TCTAGACCTT AACACACTCC
 
9121 CATCCCTGCG AGCCCAGGAA GAGGCGAGCT CAGGTGAGGG GATCAGAGGA GGGATCAAGG
 
9181 AGTCANTGTC GCCCGTOGGC CCAIGACAATT TCTACACAAA TATCACTCAT AAGGTGTTCA
 
9241 ATCGTCGTTG GTTGAGTGGC TTTCATATCA ATATTGCAGA TT/CATCATA TGGGGACTCA
 
9301 CATGCACGAG AAAATCCATC ACCACGCAGG GGACACTGAG TGGGANTTTG CCAATTTGCA
 
9361 TCCCAGCGTG CAGAGGATGC TTGAGNOGGA AGGAGAGAGA ATTCCTTGAC ATTGACAATC
 
9421 CACCGAGGTG GGAGTGCAAA GAAGGAGACA AAGATAAGGC CTACATGTAC TTCACTACCT
 
9481 GGTGTGACCT CCCAAGGCTG TCTACCCTTC CTAGTCTTGA CCCGCAGGAC GmnwraA
 
9541 TGATTGGGNA ACAACTCGCC TGTAGTAAAG GTCAAGATTC GGGGGCTGCAACCAAGTTCT
 
9601 ATAACGTCTC CCCCGAGTCC CTAGGACTCC TACATCCCAG AATGCTGTTA TTGGGATACT
 
9661 CGGAGGGGCT GATATTCAGC TACTTAAGGA GCCAACACAT TonampaG TGTCTCTATC
 
9721 ATCCTACGAT CACAGAGCTG CTTCCAAGCT TAGAGAAGTA CACCCITGAG ACAATTGACC
 
9781 AGCATGCGCG ACAACTTGGA TACCTGTTTC AAGAGGAAGAAACGGCAAAG GAGCTCTTGA
 
9841 ATGCCGGTCT CTGCCCCTAC ACACCGCGAG CGATTCCCCT GACAATCACG GAGCTAAAAA
 
9901 ACGCCGTCTG CATCACAGTC AGCCGTTCCA TCTCGGTCAC TM:CMG:ADC AAAAAGTCGA
 
9961 TTCACTTAAT GCCTGAGTCA GGGATTTCGG AGGAGGAGGT TGTAGCGGGG AGACACGCCG
 
10021 CGAGAACACT AGGTGGGCTC CTGAACATTA AGGTCCCAAA TITEXAMAANC ATCGATTGTG
 
10081 ATCTCACGAA GGGACTCCTC CCCTGGGAAC CAGAACTTCC ATCAGAGGTG CTGCAATCAG
 
10141 AAAACATTAAAATTGATGGG AAACGAGTAA CTCTTTATGC AAAGAGCCAA AAAAGAGACA
 
10201 ACTCAATCTG GGAAGAAAGA GGGTGGACAT GTTCCAACTC AAGAGAGATC CTGGCGAAAG
 
10261 GGGTTAAAAC CAAGTCGTTA TTCATCCACC AGAGTGTCCC CTCTCACCTT GACATTGATC
 
10321 CGGCCCTCAT Tcnixzmarr GGAGGGGGGC TTGGTGGCTG TGTGGTCCCC TACCTTCAAC
 
10381 ACTGGAGAAG ACCCCCAGTG ATCTTCACAA CACTTTTTAG TGAGANAWANG CGAATCTCAG
 
10441 AAGACGGGGA CCTGATCATA CCCCCTGAAT TGCTAGTTAG AGGCTTGTCT GGACGAATGG
 
10501 TAGAACGAGAACTGTTAGAG GCTGAACTCT GTGATGTGAC =CANNA= AACCGGAAAG
 
10561 CCATAGTGGA TGCAGTAAAG AGAAGGATAA AACCCAATGA GAGTGTGCTA CTGATTGATG
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10621 AGATCGAGAA TCGGGGGGAT GCAGAAGACG TCCTTCAGCA ATCCATCAGC ACTCTTTTGC
 
10681 AGTCATTGGA AAAACACTGC TCMTGACAT CTGTGCATAC CATCAGGGAG AGCAATGTGA
 
10741 AGCACTTTAC CCAGAGGTTG AACATCTTGA GGAGAGGGCG ATATGAGGCA AATTTATTTT
 
10801 GGAACCGTTA CAACAGACGT GATCAGTATG AGGCCCTCAT TGUGATTCCC AGTGAATCTA
 
10861 GGATGACAGA GTGTACCTTC TCCGTTGCGT CTGTACAGGC TGCGTTCCAA AAGATAGATG
 
10921 ATGGAATTGA GGTAGAAGCA AAACTAGAAG CCCACAGCTG GCKWOMGCCT GAGCTTCCCC
 
10981 CTCGAGAGAA GAAGATTCTG TTGGGATATG TCTCATCCGT ATTCTTAAAG CTGGGGTTGG
 
11041 TAGTGATAGA GAGGCACATG AGCTCAACTA AATTGATCGA TC12AMBANG TCTGCGGGAC
 
11101 CGCAGATGAT CTCATGGGAA GAGAAACAAA CGCATAGATC TTGGGCTAGC ACAGACAGCA
 
11161 TCAAGGAAAA GGGAGTGACA CAAGACAGGA TCATGGCACT TcamorPc GCGTGGACTC
 
11221 TGAAGGGACT TAAACATGGG GIOXIGINCA CGAACATGGA TGCAGTAGTT GAGAAAACTG
 
11281 TCTACATAAC CCACGGACCA AGACTTTGCG CACTTGACGA GAAACCTCGA GTTCAGTATG
 
11341 CTGAATTCAA GCTTCAGAGC AAGAAAAGAG TAGAAGATCT TAAAGGATAC CTTGGAGCGC
 
11401 TcornmAlccT TGAGACCTTC TTCCOOTTGG GGGATCGCTG Atcaggacaa  acgagaaaga
 
11461 ggtcaacgct totaaaacca tgaagcaaac acagcagaca gaaaaaaact ggatttgtcc
 




The final ORF, extending from nt 5490-11441, encodes the presumed L 
protein, which is the largest and most highly conserved of SHRV's proteins. Unlike 
the rest of the SHRV proteins, the L protein has more identity with IHNV-L than 
VHSV-L, with 58 and 52 percent identity, respectively. In addition to similarity to 
the closely related viruses, significant homology exists between the Lproteins from 
SHRV and other nonsegmented negative-stranded RNA viruses (Table 3.1). 
Gene Junctions 
The gene junctions of SHRV are shown compared with the gene junctions of 
the three recognized members of the genus Novirhabdovirus (Fig. 3.3). The highly 
conserved 19 nucleotide sequence AGAYAG(A7)YGGCAC contains both the 
putative polyadenylation and transcriptional start signal. Analysis of the 3' end of 
cDNA sequences from mRNA of the P, G, and NV genes verified that the (A7) 
sequence represents the polyadenylation sequence for SHRV (data not shown). 
Because the transcriptional start signal for IHNV has conclusively been shown to be 
5'-GCAC-3' (Chiou & Leong, 1996) which is commonly found  among 
Novirhabdoviruses, we presume this to be the transcriptional start signal for SHRV 
as well. 
Genomic Termini 
The genome ends of SHRV are complementary (16/17 positions), a feature 
which has been observed in all rhabdoviral genome ends (Fig. 3.4A). Comparison 
of the genome ends between SHRV and IHNV shows that 11/12 of the extreme 
genomic nucleotides are identical between SHRV and IHNV, but no other significant 
homology occurs at the genome ends (Fig. 3.4B). SHRV and IHNV both have G as 
their terminal nucleotide whereas all other termini which have been sequenced have A 
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Fig. 33. (A) Positive strand intergenic regions among all Novirhabdoviruses. 
Blocks represent regions identical in all four genomes. (B) Consensus 
intergenic regions of viruses from four different rhabdoviral genera. Arrows 
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SHRV  5'- GTATCAAAAAAGATGATGATACTTGGAAGAAGAGATGAA..
  ..GATITGTCCTAGAAAAAAATATATCATCITITTCTATAC -3'
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IHNV  5'- GTATAAAAAAAGTAACTTGACTAAGCTCAGAAGGACACA..
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Nokola 5'- ACGCTTAACAACCAGATCAAAGAAGACACAGATAGTATC.. ..GATTATTITTGAR-frITATATGOTTTTTTTGTTAAGCGTC-3'
 
SYNV  5'-AGAGACAGAAACTCAGAMATACAATCACCGTAGATTAA.. ..ATAAATGGGGTATAGGGATTGTTCTGAGCTTTTGTCICT -3'
 
SYTV
  5'-ACACCACCAGATACATTCTOTAAATAGTTTGCTGTGGTT..  ..CCTCGCAGGCACACATGGCGGCTRIGGATATGGTGGTGT -3'
 
VSV-IN 5'- ACGAAGACAAACAAACCATTATTATCATTAAAAGGCTCA..
  ..TTGTGGITTTTATTITTTATCTGGTITTGTOGTCTTCGT -3'
 
Fig. 3.4. (A) Complementarity between rhabdoviral genome termini. Vertical lines 
represent complementary nucleotides. (B) Comparison of 5' and 3' ends between 
rhabdoviral genomes. Vertical lines represent identical sequences. 61 
Phylogenetic Analysis 
A phylogenetic analysis using the predicted amino acid sequences of 27 
aligned L proteins was conducted (Fig. 3.5). Nodes which were identified 90 or 
more times after bootstrapping (see figure legend) are shown in bold and will be 
referred to as nodes which received high confidence. The tree confirms with high 
confidence that the SHRV-L protein  groups with the L proteins from the 
Novirhabdovirus genus. In addition, this tree confirms with high confidence that the 
evolutionary relationship of the L proteins from the  genre Morbillivirus, 
Paramyxovirus,  Pneumovirus,  Filovirus,  Lyssavirus,  Vesiculovirus,  and 
Nucleorhabdovirus as well as the family Filoviridae,  are in agreement with the 
current taxonomic organization as assigned by the International Committee on 
Taxonomy of Viruses (ICTV). The phylogenetic tree suggests with high confidence 
that the Lyssavirus and the Vesiculovirus L proteins developed from a common 
ancestor separate from the other Rhabdoviridae, and that the Morbillivirus and the 
Paramyxovirus L proteins developed from a common ancestor separate from the 
other Paramyxoviridae. The tree supports, although not with high confidence, the 
evolutionary relationship of the L proteins from the  genera Rubella virus and 
Bornavirus and the family Rhabdoviridae recognized by the 1C1'V. The only node 
which disputes the current taxonomic organization is the assignment of the genus 
Pneumovirus within the family Paramyxoviridae. This analysis indicates that the L 
proteins from the Filoviruses and the Pneumoviruses developed from  a common 
ancestor separate from all other Mononegavirales, which supports the previously 
proposed notion that this taxonomic organization should be reevaluated (Stec et d.  , 
1991). However, this grouping did not receive a high confidence score, and only 
reflects the evolutionary history of the L proteins and not of the whole viruses. 
Discussion 
We have sequenced the complete genome of SHRV. The analysis of its 
complete genome suggests that SHRV should be classified as a Novirhabdovirus. 
There are five lines of evidence which support this assignment. First, a previous 
phylogenetic analysis using rhabdoviral G proteins grouped SHRV's G protein with 62 
Fig. 3.5. Phylogenetic Analysis (A) Alignment of highly conserved regions of 
selected polymerase proteins.  Alignments were created using the program 
CLUSTALW (GCG). Blocks where all sequences were unambiguously aligned are 
shown. Numbers represent the amino acid position of blocks. (B) Phylogenetic 
relationship among rhabdoviral polymerase (L) proteins. The L aligned amino acid 
sequences included: Measles virus (1644270), Rinderpest virus (1370293), Phocine 
distemper virus (PDV, 1707654), Canine distemper virus (CDV, 548835), Hendra 
virus (3273497), Porcine Rubeulavirus (2121316), Sendai virus (1710716), Human 
Parainfluenza virus (HPV, 67113), Mumps virus (401032), Simian virus 5 (SV5, 
464698), Simian Parainfluenza virus 41 (SPV41, 548838), Newcastle disease virus 
(NDV, 133604), Human respiratory syncytial virus (HRSV, 1016281), Avian 
Pneumovirus (APV, 1688090), Marburg virus (1350906), Ebola virus (1041214), 
Mokola virus (Y09762), Rabies virus (133609), Vesicular stomatitis virus (VSV, 
336028), Vesicular somatitis virus - new jersey (VSV -NJ, 133616), Snakehead 
Rhabdovirus, Infectious hematopoietic necrosis virus (IHNV, 975667), viral 
hemorrhagic septicemia virus (VHSV, 4138677), Sonchus yellow net virus (SYNV, 
401034), Rice transitory yellowing virus (RTYV, 2961429), and Boma disease 
virus (BDV, 473840). The numbers in parenthesis are the genebank accession 
numbers of the sequences used. Analysis was performed using the regions shown 
above. The tree shown was constructed using the protdist program (GCG). The 
amino acid alignment was bootstrapped 100 times using the program seqboot (GCG) 
and the bootstrapped data was analysed with the program protdist (GCG) followed 
by neighbor (GCG) using the default settings. Lines shown in bold illustrate the 
nodes which were identified in 90 or more of the bootstrapped trees. 63 
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those of other Novirhabdoviruses (Chapter 2). Second, the phylogenetic analysis 
performed here groups L protein of SHRV with those from other 
Novirhabdoviruses.  Third, there is significant homology between the intergenic 
regions and genomic termini of SHRV and those of other Novirhabdoviruses, while 
very little, if any, homology with other rhabdoviral genera. Fourth, of the six ORFs 
in the SHRV genome, five are most similar to orthologous proteins from viruses 
belonging to the Novirhabdovirus genus. Finally, and perhaps most importantly, the 
SHRV genome has a sixth ORF between the G and L genes, which is a 
distinguishing feature of all Novirhabdoviruses. 
An interesting observation was made in this study concerning the genomic 
termini of rhabdoviruses. SHRV and IHNV are the only rhabdoviral genomes which 
initiate with the nucleotide (G), all other known genomes initiate with the nucleotide 
(A) (Fig. 3.3).  Also, it has recently been shown that IHNV initiates mRNA 
transcription with the nucleotide (G) (Chiou & Leong, 1996), whereas all other 
rhabdoviruses initiate transcription with the nucleotide (A). We therefore propose 
that each rhabdovirus genus has a nucleotide preference for the initiation of 
transcription and replication. 
The previous phylogenetic analysis using rhabdoviral G proteins indicated 
that the genus Novirhabdovirus has a split lineage with IHNV and HIRRV evolving 
from one lineage and SHRV and VHSV evolving from a separate lineage (Johnson et 
cd., 1999). The phylogenetic tree produced in this study supports the grouping of 
SHRV with VHSV (Fig. 3.5), but as the sequence of HIRRV-L was not available, 
we could not analyze the grouping of IHNV with HIRRV. Further support for the 
notion that SHRV groups with VHSV comes from the observations that the N, P, 
M2, and G proteins of SHRV are all most similar to orthologous proteins from 
VHSV (Table 3.1). However, we also observed that the SHRV-L protein is more 
similar to IHNV-L than to VHSV-L (Table 3.1), which apparently contradicts the 
results of the phylogenetic analysis performed with the L protein. Upon closer 
analysis of the amino acid alignment of these three L proteins, we observed that the 
VHSV-L sequence contained several large ambiguous gaps, which affected the 
overall similarity to SHRV. In addition, in several locations the sequence of VHSV­
L was found to be out of frame with the other two L proteins. We therefore believe 
that the previous grouping of VHSV with SHRV is correct, but that VHSV-L has 65 
either undergone recent extreme mutagenesis, or that the sequence of VHSV-L used 
in our comparison contains errors. 
The phylogenetic analysis of the L protein generally agreed with the accepted 
taxonomy assigned by the ICTV.  One important finding relating to the 
Rhabdoviridae family is the observation that the Lyssavirus and Vesiculovirus genera 
form a separate Glade from the rest of the rhabdoviruses, suggesting that these two 
viruses may have a common lineage. Our analysis also showed that the L proteins 
from the genus Pneumovirus are distinct from those of other Paramyxoviridae, and 
could be more closely related to the Filoviridae family. Our analysis based on the L 
protein sequence suggests that the Pneumovirus genus should be classified as a 
separate virus family among the Mononegavirates. 
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Abstract 
The generation of a fully viable recombinant snakehead rhabdovirus (SHRV), 
a fish rhabdovirus that appears to belong in the genus Novirhabdovirus, from cloned 
cDNA is described here. Expression of a positive-stranded RNA copy of the SHRV 
11,550 nucleotide genome along with the viral nucleocapsid (N), phosphoprotein 
(P), and polymerase (L) proteins resulted in the regeneration of viable SHRV virus. 
To verify that the virus produced in the transfected cells was indeed recombinant-
DNA derived virus, a unique restriction site was engineered into the SHRV genome 
between the non-virion (NV) and L genes. The preservation of this site in the 
recombinant was confirmed both by PCR-restriction fragment length polymorphism 
(RFLP) and by direct sequencing of the viral genomic RNA produced by the 
transfected cells. This is the first report of reverse genetics on a non-mammalian, 
negative-stranded RNA virus. The ability to generate SHRV with directed changes 
in its genome should provide us with the tools to begin a study of the viral NV gene 
and the regulatory elements of the Novirhabdoviruses. 
Introduction 
The ability to manipulate directly the genomic sequence of a virus provides a 
powerful and specific means of elucidating the relationship between genetic 
information and biological function.  For RNA viruses, correlating biological 
function with specific sequence changes can only be carried out if infectious virus 
particles can be recovered from viral cDNA clones. Because the RNA particle of a 
positive-stranded RNA virus can often serve both as the genomic template and as the 
viral messenger RNA, recovery of infectious virus requires only the RNA genome. 
However, with negative-stranded RNA viruses, the viral RNA genome is only 
infectious if it is introduced along with all the viral proteins required for transcription 
and replication. 
In 1994, Schnell et al. reported the first recovery of a recombinant negative-
stranded RNA virus entirely from cDNA clones. Their strategy involved expressing 
a full-length positive-stranded (antigenomic) RNA copy of the rabies virus genome 
under the control of a T7 RNA promoter (Schnell et al., 1994). The genome was 69 
expressed in a virus susceptible tissue culture cell line along with the viral 
nucleocapsid (N), polymerase (L) and phosphoprotein (refered to here as P, but also 
known as NS or Ml) proteins. High levels of cytoplasmic T7 RNA polymerase 
were induced by pre-infecting cells with the recombinant vaccinia virus vTF7-3 
(Fuerst et al., 1986), which is designed to overexpress the T7 polymerase. In the 
years since this first report, similar methodologies have been used successfully to 
produce several other recombinant segmented and non-segmented negative-stranded 
RNA viruses (for reviews see Conzelmann, 1996; Rose, 1996). To date, only 
mammalian RNA viruses have been expressed successfuly with these procedures. 
Snakehead rhabdovirus (SHRV) is a rhabdovirus of warmwater fish, and it 
was isolated from a diseased snakehead fish (Ophicephalus struatus) during an 
epizootic outbreak in Thailand (Kasornchandra et al., 1992b). The disease caused 
characteristic necrotic ulcerations in both wild and pond-cultured fish throughout 
southeast Asia (Kasornchandra et al., 1991). SHRV tentatively belongs to the 
rhabdoviral genus Novirhabdovirus (Johnson et al., 1999), and is closely related to 
two of the world's most economically important fish pathogens, viral hemorrhagic 
septicemia virus (VHSV) and infectious hematopoietic necrosis virus (IHNV). 
Although SHRV is not the prototype Novirhabdovirus, it is the best suited virus 
from its genus for performing reverse genetics experiments as it is the only member 
which can replicate at the optimal temperatures for vaccinia virus infection and T7 
polymerase transcription. 
We report here the generation of recombinant snakehead rhabdovirus 
(SHRV) entirely from cDNA clones. This marks the first time reverse genetics has 
been performed on a non-mammalian negative-stranded RNA virus. The ability to 
manipulate the SHRV genome will enable us to examine the regulatory elements and 
NV genes of the Novirhabdoviruses and could be used for developing recombinant 
virus vaccines. 70 
Materials and Methods 
Oligonucleotides 
The oligonucleofides used in this study are listed in Table 4.1. The locations 
of several of these primers are shown in Fig 4.1A 
Cells and Viruses 
Epithelioma papulosum cyprini (Fijan et al., 1983) (EPC) cells were used for 
viral propagation. The cells were grown at room temperature in minimal essential 
medium (MEM) supplemented with 10% fetal calf serum and 2mM L-glutamine. 
The SHRV was obtained from Dr. John Fryer, Oregon State University. EPC cells 
were infected with SHRV at a multiplicity of infection (MOI) of 0.5 and incubated at 
room temperature until there was 70% cytopathic effect (20 h). The infected cells 
were collected and used in subsequent RNA purification. 
RNA Purification 
Total cellular RNA was extracted from SHRV-infected EPC cells with 
RNAzoI (Tel-Test, Inc., Friendswood, TX) according to the manufacturer's 
instructions. 
PCR and cDNA. 
SHRV cDNA was prepared by mixing 1 ng of total RNA with 50 pmol of 
random hexamers, 20 nmol dNTP, 4 ut 5X AMV-RT buffer, 10 units RNasin 
(Promega, Madison, WI) and 10 units AMV-RT (Reverse Transcriptase, Promega) 
in a total volume of 20 III, and incubated for 1 h at 42°C. Following reverse 
transcription, cDNA was mixed with 900 [IL H2O and 1 !IL from the cDNA reaction 
mixture was used as template for each of the subsequent PCR amplifications. 71 
SHRV Primers  Primer 
locations 
ME 602  CCGGATCCI I GTAATACGACTCACTATAGGGG  1-31 
TATCAAAAAAGATGATGATACTTGGAAGA 
ME 575  GGAGAGATATCAAGAATCAAACCGAG  137-162 
ME 578  GGACCGGGGCTGATACTGATGGAAACACC  280-308 
ME 568  CGAGAGTGCITAAATCITTGAAACCC  1522-1547 
ME 526  AAGGCTGAACTCACAAAGTGAC  2230-2251 
ME 531  ATATATGAAGACAACGACTCCTGGTAGA  5239-5266 
ME 579  CCGCGGTGGCATTCAATCC  5456-5484 
CCCGACTGAAACGGAC 
ME 564  GCACTCCACAAAAAGGCGCT  8205-8224 
ME 605  CACGGTACCGGGCTAGCACAGACAGCATC  11143-11162 
ME 604  CACGGTACCGGCGCCTCAATCCCCGAACIT  497-476 
ME 540  TCCICCTGAAGGTIVICITGTGTCITGG  1588-1561 
ME 569  C I CCTGTCAGGATITTAGCACTCTC  2328-2304 
ME 527  GTTTCATGITIGGGAGCGTC  3224-3205 
ME 580  CCGCGGCGTTGTGGGITGATGGAGGGCCTAGT  5451-5424 
ME 554  CAAATATCICGTGGACTCGTG  7299-7279 
ME 585  ACCATGGACCGGATCAATITCTCGATTC  8275-8248 
ME 581  TTCTCGTTTGTCCI'GATCAGCGATCCCCC  1 1457 -1 1429 
ME 603  AGGTCGGACCGCGAGGAGGTGGAGATGCCATGCC 11550-11521 
GACCCGTATAGAAAAAGATGATATATTITTITCIA 
T7 primers 
ME 550  CCGGATCCATGAACACGATTAACATCGCI'
 
ME 551  CGAATTCTTACGCGAACGCGAAGTCC
 
pMJ construction primers 
ME 520  CCGACGTCCGATGACGATAAGGATCCGA
 








  AGertGeTCTCCCITAGCCATCCGAGTGGACGACGTCC 
TCCTICGGATGCCCAGGTCGGACCG 
Table 4.1. Primers used in this study. 72 
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Fig. 4.1. Vector construction. (A) Illustration of the six PCR fragments used to 
construct the full length genome and relevant restriction sites. Restriction site lines 
which pass through the primer indicate restriction site was designed into the primer 
and lines which pass through the genome line indicate sites naturally occured in the 
genome. (B) Schematic of the four plasmids used in the successful recombinant 
attempt. 73 
Amplifications were performed in an Amplitron II programmable heating block 
(BarnsteadlThermolyne, Dubuque, IA). All PCR reactions were performed with the 
same basic parameters with 30 cycles of: 95°C for 10 sec, 55°C for 1 min and 72°C 
for 3 min. Extension times were varied depending on the PCR size. 
Sequencing 
All DNA sequence analyses were performed by the Oregon State University 
Center for Gene Research and Biotechnology Central Services Facility on a 373 
DNA sequencer (DuPont Applied Biosystems, Boston, MA). To avoid PCR error, 
all regions of the SHRV genome were sequenced at least three times. 
Luciferase Assays 
Luciferase assays were performed with either 6-well (10 cm2), or 98-well (1 
cm2) monolayers of EPC cells. Cells were transfected with the appropriate vectors 
using the Lipofectamine Plus Reagent (Life Technologies, Gaithersburg, MD) and 
assayed 24 h post-transfection using the Luciferase Assay System (Promega), 
according to the manufacturers' instructions. 
Plasmids 
The plasmid pcDNA3 -N was created by PCR amplifying the SHRV-N gene 
from SHRV cDNA using Pfu polymerase (Stratagene, La Jolla, CA), with primers 
ME 575 and ME 540, and blunt end cloning the fragment into the EcoRV site of 
pcDNA3 (InVitrogen, San Diego, CA). The plasmid pcDNA3-P was made in the 
same manner as pcDNA3-N except primers ME 568 and ME 569 were used. 
Plasmid pcDNA3-T7 was created by PCR amplifying the T7 RNA polymerase gene 
from bacteria BL21 LysE (Novagen, Madison, WI) using Platinum Taq HF (Life 
Technologies, Gaithersburg, MD), with primers ME 550 and ME 551, and 
subcloning the fragment into the BamHI and EcoRI sites of pcDNA3 using 74 
restriction sites designed into the primers. The plasmid pcDNA-L was created in a 
four-step cloning process. First, the 5' and 3' ends of SHRV-L were PCR amplified 
from SHRV cDNA using Platinum Taq HF with primers ME 579 and ME 585, and 
ME 564 and ME 581 (PCR products 4 and 5, Fig. 4.1A), respectively. The two 
fragments were then subcloned into pCRXLTopo (InVitrogen) using the 
manufacturer's instructions, creating pCRXLTopo-3'L and pCRXLTopo-5'L. 
Next, the 5' end of SHRV-L was subcloned from pCRXLTopo-5'L into pcDNA3 
using the vector's unique HindllI and Apal sites, creating pcDNA3-5'L. Finally, the 
3' end of SHRV-L was added by partially digesting pCRXLTopo-3'L with Bpul and 
Spel and subcloning the 3.2 Kb fragment into the unique Bpul and XbaI sites of 
pcDNA3-5'L, creating pcDNA3-L. Plasmid pTM1-Luc was created by subcloning 
the luciferase gene from pGL2-Basic (Promega) into the multiple cloning site of 
pTMI (Elroy-Stein etal., 1989). 
Creation of the plasmid pMJ-SHRV was a nine step cloning process. First, 
the T7 transcriptional stop site and part of the multiple cloning site of vector pRSET-
B (InVitrogen) was PCR amplified using Pfu polymerise, with primers ME 520 and 
521, and subcloned into the Af/III and AatII sites of pUC19 using restriction sites 
designed into the primers, creating pUC19+. Second, a linker containing part of the 
Hepatitis delta virus (HDV) ribozyme sequence (Perrotta & Been, 1991), created by 
annealing oligonucleotide primers ME 522 and ME 523, was cloned into the EcoRI 
and HindIII sites of pUC19+, creating pMJ. Third, the 3' end of the SHRV 
genome, positive strand, was PCR amplified from SHRV cDNA (PCR 6, Fig. 4.1A) 
using Platinum Taq HF, with primers ME 605 and ME 603, and subcloned into the 
KpnI and Rsrll sites of pMJ using sites incorporated in the primers, creating 
pMJ+3'. Fourth, the 5' end of the SHRV genome was PCR amplified from SHRV 
cDNA using Platinum Taq HF, with primers ME 602 and ME 604 (PCR 1, Fig. 
4.1A), and subcloned into the KpnI and BamHI sites of pMJ +3' using sites 
incorporated in the primers, creating pMJ+3'+5'. Fifth and Sixth, the 5' half of the 
genome was PCR amplified from SHRV cDNA using Platinum Taq HF in two 
PCRs - the first with primers ME 578 and ME 527, and the second with primers ME 
526 and ME 580 (PCRs 2 and 3, Fig. 4.1A). Both products were subcloned into 
pCRXLTopo, creating pCRXLTopo-578/527 and pCRXLTopo-526/580. Seventh, 
vector pCRXLTopo-526/580 was digested with XmaI and the 4.8 Kb fragment was 
subcloned into the 3.8 Kb fragment of pCRXLTopo-578/527 partially digested with 75 
Xmal, creating pCRXLTopo-578/580. Eighth, pCRXLTopo-578/580 and peDNA3­
L were digested with Apai and SacII and the 6 Kb fragment from pcDNA3-L was 
cloned into the 9 Kb fragment from pCRXLTopo-578/580, creating pCRXLTopo­
578/581. Finally, pCRXLTopo-578/581 and pMJ were digested with Kasl and 
Nhel and the 11 Kb fragment of pCRXLTopo-578/581 was subcloned into pMJ, 
creating pM3 -SHRV. Several errors found in the completed genome, which 
presumably occurred as a result of PCR error, were fixed either by oligo-directed 
mutagenesis, or by cutting and pasting in error-free fragments. The construction of 
the entire plasmid was verified by DNA sequencing. 
Transfections 
All Transfections were performed in 6-well (10 cm2) plates with EPC cells 
seeded at a concentration of approximately 5 x 106 cells/well approximately 16 h 
before the transfection. At the time of transfection, the cell monolayers were 70%­
90% confluent. Transfections were performed using the Lipofectamine Plus Reagent 
(Life Technologies, Gaithersburg, MD) according to the manufacturer's instructions. 
In experiments where the cells were pre-infected with vaccinia, thirty minutes before 
the cells were overlaid with the transfection media, they were infected with vaccinia 
virus vTF7-3 (Fuerst et al., 1986), which was kindly provided by Doug Grosenbach 
(Oregon State University). The infection was carried out at an MOI of 5 in 200 RI, 
of MEM-0. Thirty min after infection, the cells were rinsed 2X with MEM-0 and 
overlaid with transfection media. Following transfection, the cells were incubated at 
31°C. 
RFLP Analysis 
RNA from the first passage of the presumed recombinant SHRV was 
collected as described above. Two identical tubes for reverse transcription were set 
up, the first was prepared by mixing 1 lig of total RNA with 50 pmol of random 
hexamers, 20 nmoles dNT'P, 4 pi, 5X AMV-RT buffer, 10 units RNasin ( Promega) 
and 10 units AMV-RT (Promega) in a total volume of 20 ILL. The second tube 76 
included exactly the same ingredients except it received 1 iLtL H2O instead of AMV­
RT. Both tubes were incubated for 1 h at 42°C, after which they were diluted with 
80 µL H2O and 1 ttL was used in the subsequent PCR reaction. PCR was 
performed using Platinum Taq HF with primers ME 531 and ME 554. Three PCR 
reactions were performed, two with the reverse transcription reaction just described 
and a third with wild type SHRV cDNA. Standard PCR amplification was 
performed except the reaction was carried out for only 25 cycles. Following PCR, 
the reaction mixture was divided into three portions. The first portion was analyzed 
by agarose gel electrophoresis, the second was digested with SacII and then analyzed 
by agarose gel electrophoresis, and the third was submitted for direct sequencing 
with primer ME 531. 
Plaque Assay and Immunohistochemistry 
Plaque assays were used to determine the titer of the wild type SHRV as well 
as recombinant SHRV (Burke & Mulcahy, 1980). Infected cells were incubated at 
31°C for 24 h, after which they were washed once with phosphate buffered saline 
pH 7.6 (PBS), fixed with 3.7% formaldehyde in PBS for 15 min, and washed five 
times with PBS.  Monoclonal antibody A-9H to the SHRV glycoprotein 
(Kasomchandra etal., 1992a) was applied to the cells. After a one hour incubation 
at RT, the cells were rinsed and then were stained using the Vectastain ABC kit and 
Alkaline Phosphatase Substrate Kit 1 according to the manufacturer's instructions 
(Vector, Burlingame, CA). 
Results 
77 Expression Systems 
The first challenge in developing the recombinant system was finding a way 
of expressing T7 RNA polymerase in the cytoplasm of EPC tissue culture cells. 
Two potential systems were investigated.  The first system involved the 
overexpression of T7 polymerase using a eukaryotic expression vector. The T7 77 
polymerase gene was PCR amplified from the T7-expressing bacterial cell line BL21­
LysE (Novagen) and subcloned into cloning vector pcDNA3 (InVitrogen). To test 
the pcDNA3-T7 vector, a reporter vector with luciferase under T7 promoter control 
was constructed. The reporter vector was constructed by cloning the luciferase gene 
from pGL2-Basic (Promega) into the T7 promoter expression vector pTM1 (Elroy-
Stein etal., 1989). Upon cotransfection of EPC cells with pcDNA3-T7 and pTM1­
Luc (Fig. 4.2A ) we saw a 10-20 fold increase in luciferase production over cells co­
transfected with pTM1-Luc and pcDNA3. 
The second potential system for expressing T7 polymerase involved the 
recombinant T7 polymerase expressing vaccinia virus, vTF7-3 (Fuerst etal., 1986). 
Vaccinia virus is a promiscuous virus which is able to infect fish cells, but is unable 
to complete a productive infection (Dennis Hruby and Christine Franke, personal 
communication). To test whether vTF7-3 could produce T7 polymerase in EPC 
cells, the cells were either infected or mock infected with vTF7-3, and subsequently 
transfected with T7 expression vector pTM1-Luc (Fig. 4.213). Cells pre-infected 
with vTF7-3 expressed approximately 10 fold higher levels of luciferase. At 24 
hours post-infection, EPC cells did showed some obvious signs of viral infection, 
including cell rounding and some cell death, but the majority of infected cells 
remained attached to the monolayer. 
Vector Constructs 
Several vectors had to be constructed before a recombination attempt could be 
made. The first constructed plasmids were expression vectors for the viral proteins 
N, P, and L, which are presumably required for SHRV transcription and replication. 
These genes were all amplified by PCR (see materials and methods) and subcloned 
into the expression vector pcDNA3 (Fig. 4.18). The vector, pcDNA3, was 
particularly well suited for this project as it contains both a cytomegalovirus (CMV) 
promoter, which has been proven to be highly active in fish cells (Anderson et al. , 
1996), and a T7 promoter. 
The final vector which needed to be constructed was one encoding the entire 
SHRV genome. The details of the construction of this vector (pMJ-SHRV) are 
explained in the Materials and Methods section. To summarize, the basic features of 78 
Fig. 4.2. T7 luciferase reporter assays. (A) Columns 1 and 2 are duplicate samples 
transfect with pTM1-Luc and pcDNA3. Columns 3 and are 4 duplicate samples 
transfected with pTM1-Luc and pcDNA3-T7. (B) Columns 1 and 2 are duplicate 
samples mock-infected, then transfected with pTM1-Luc. Columns 3 and 4 are 
duplicate samples infected with ATT1.7-3, then transfected with pTM1-Luc. Note: 
transfections in (A) and (B) were not identical and thus cannot be compared with 
one another directly. 79 
the constructed vector are (Fig 4.1B): a pUC19 backbone containing the origin of 
replication and an ampicillin resistance gene, a T7 promoter positioned so that the 
first transcribed nucleotide represented exactly the first nucleotide of the positive 
strand of the SHRV genome, the full-length 11550 nt SHRV genome, the hepatitis D 
virus ribozyme sequence, which is positioned to self-cleave the RNA at exactly the 
last nt of SHRV's genome, and a T7 transcriptional stop site. A single alteration was 
made in the genome of SHRV. Between the NV and L genes, at the overlap of 
primers ME 579 and ME 580 (nt 5451), a Sac II restriction site was added. 
Transfections 
Initial attempts to obtain recombinant SHRV were performed with the 
pcDNA3-T7 expression vector. Five. wells of EPC cells were transfected each with: 
0.2 ti.g pcDNA3-T7, 0.4 gg pMJ-SHRV, 0.2 gg pcDNA3-N, 0.15 gg pcDNA3-P 
and, 0.05 gg pcDNA3-L. A sixth well was transfected with just pcDNA3. After 
six days no CPE was seen. Cells were then trypsinized, subjected to three rounds of 
rapid freeze/thaw, and the supernatant was placed on fresh EPC monolayers. After 
six days, there was still no visible CPE. The transfection was repeated, but again no 
CPE was seen. 
The second set of experiments to produce recombinant DNA derived SHRV 
was carried out by preinfecting EPC cells with vaccinia virus vTF7-3, and then 
transfecting with the viral vectors. In this experiment three wells were pre-infected 
with vTF7-3, and then transfected with: 0.5 gg pMJ-SHRV, 0.25 gg pcDNA3-N, 
0.20 gg pcDNA3-P and 0.5 gg pcDNA3-L. A fourth well was pre-infected with 
vTF7-3 and transfected with 1 tig of the parental plasmid pcDNA3, and a fifth well 
was just transfected with 1 itg of the parental plasmid pcDNA3 with no pre-vaccinia 
treatment.  In this experiment, within 48 h of transfection the cells in all 3 
experimental wells had undergone total CPE (all cells were nonadherent), while the 
cells in both negative controls were still in complete monolayers. At 48 h, 
supernatant fluids from all five wells were collected, a portion was diluted 1:100 in 
MEM-10, and placed on a fresh monolayers, and the remainder was frozen. Within 
48 hours, cells overlaid with diluted supernatant from experimental wells had 80 
undergone characteristic CPE typical of an SHRV lytic infection, while cells overlaid 
with supernatant from negative control wells were normal monolayers. 
The experiment was repeated, and again CPE was only seen in wells 
expressing all SHRV plasmids, but not in negative control wells. 
SHRV Verification 
In order to verify the recombinant nature of the infectious agent, the 
engineered Sadl restriction site in the SHRV genome was verified. To do this, RNA 
was collected from the first passage of virus, and the RNA was either reverse 
transcribed or mock reverse transcribed. Following the reverse transcription, cDNA 
from both reactions as well as cDNA from wild type SHRV was PCR amplified 
using primers which flank the engineered restriction site.  Following PCR 
amplification, reactions were electrophoresed on an agarose gel before and after 
digestion with Sac 11 (Fig. 43A). A band was amplified from the wild type SHRV 
cDNA and the reverse transcribed recombinant RNA, but not from the mock reverse 
transcribed RNA. Following digestion with Sac!!, the size of the wild type SHRV 
PCR product remained unchanged, while the PCR product from the recombinant 
RNA template was cleaved by the enzyme (lower band is not visible in gel). Finally, 
DNA sequencing of the PCR reaction verified the identity of the engineered 
restriction site (Fig. 43B). 
Plaque Assay and Immunohistochemistty 
The virus produced in the original transfection was measured by plaque 
assay. The plaques produced by recombinant virus as well as wild type virus were 
also stained immunohistochemically with a monoclonal antibody to the viral 
glycoprotein. The result of the plaque assay showed that after a single freeze thaw, 
there were approximately 107 plaque forming units/mL in the recombination 
supernatant. Size and staining pattern of wild type and recombinant viral plaques 
were identical (data not shown). 81 
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Fig. 4.2. T7 luciferase reporter assays. (A) Columns 1 and 2 are duplicate samples 
transfect with pTM1-Luc and pcDNA3. Columns 3 and are 4 duplicate samples 
transfected with pTM1-Luc and pcDNA3-T7. (B) Columns 1 and 2 are duplicate 
samples mock-infected, then transfected with pTM1-Luc. Columns 3 and 4 are 
duplicate samples infected with vTF7-3, then transfected with pTM1-Luc. Note; 
transfections in (A) and (B) were not identical and thus cannot be compared with 
one another directly. 82 
Discussion 
Although both methods for expressing T7 RNA polymerase were successful 
in transient reporter assays, only the vaccinia system was successful in producing 
recombinant virus. This is probably due to the fact that a higher percentage of the 
cells express T7 RNA polymerase when the vaccinia system was used. Transfecti on 
efficiencies using eukaryotic expression vectors in EPC cells usually reach a 
maximum of 1-10%, whereas the vaccinia expression system presumably induced 
expression in virtually every cell. It is difficult to give an accurate estimate of how 
many cells actually produced live SHRV. However, there was little if any visible 
CPE at 24 h post-transfection, a finding that would indicate that less than 1% of the 
cells produced virus. By 48 h, CPE was complete in all the wells with experimentally 
transfected cells. This finding suggested that infectious virus was produced in a few 
cells and the released virus, in turn, infected the rest of the monolayer. 
Verification that the SHRV produced in the transfected cells was indeed 
recombinant DNA-derived virus was carried out by RFLP analysis and direct DNA 
sequencing. In the RFLP analysis, the fact that there was no band in the well 
containing the mock reverse transcribed PCR reaction proves that the PCR 
amplification was not the result of residual plasmid DNA, and the fact that the 
fragment in only the recombinant well contained a Sad! site proved that the virus 
was recombinant. Finally, the plaque assay proved that the CPE was a result of 
viable SHRV. Together this evidence indicates that the SHRV produced via DNA 
transfection was indeed recombinant. 
This study marks the first occasion in which reverse genetics has been 
performed on a non-mammalian negative-stranded virus. Now that the system is 
established, it will be used to address such perplexing questions as, what gene or 
genes affect virulence, what is the key to host-specificity, and what is the function of 
the mysterious NV protein. In addition, future work with this genus could result in 
the development of much needed viral vaccines for fish. 83 
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Conclusion 
The complete genome of snakehead rhabdovirus (SHRV) was cloned and 
molecularly characterized. This was initially accomplished through the sequence 
determination of its glycoprotein gene and the phylogenetic analysis of this gene with 
orthologous genes from other rhabdoviruses. The phylogenetic analysis revealed 
that SHRV groups with viruses of the genus Novirhabdovirus. The full-length 
glycoprotein was expressed in mammalian cells to investigate its potential use in the 
production of pseudotyped retroviruses. 
The sequence of the entire SHRV genome of 11.6 kb was determined, and all 
encoded proteins, intergenic transcriptional control motifs, and the leader and trailer 
regions were identified. The genome was found to encode six proteins including a 
nucleoprotein, a phosphoprotein, a matrix protein, a glycoprotein, a small-
presumably non-virion--protein, and a polymerase protein. The presence of a non-
virion protein, which is the hallmark feature of all Novirhabdoviruses, supported 
SHRV's identity as a member of the Novirhabdovirus genus, despite the fact that the 
non-virion protein showed no homology with any known protein. 
A system was developed to express a full-length, error-free positive-strand 
copy of SHRV's RNA genome along with all of the SHRV proteins required for 
viral replication within the cytoplasm of a virus-susceptible host cell. These factors 
collectively allowed the recovery of live virus entirely from cloned cDNAs. A unique 
restriction site was engineered into SHRV's cDNA genome, and the presence of this 
restriction site was verified following virus recovery, proving the recovered virus 
was indeed a live recombinant virus. To our knowledge this achievement marks the 
first time in which reverse genetics has been performed on a nonmammalian 
negative-stranded RNA virus. 86 
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